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ABSTRACT
Roles of nitric oxide and shear stress in the regulation of microvessel permeability
in intact rat mesenteric venules
Sulei Xu
Mechanical forces have been indicated to play important roles in the regulation of
inflammatory cell interaction with endothelium resulting in localized leakage formation and
contributing to many disease-associated microvascular dysfunctions. However, most of the
mechanical force related studies were conducted in vitro. The underlying mechanisms are
still controversial. There is a need to investigate how shear stress regulates the endothelial
cell (EC) signaling and related vascular barrier function using intact microvessels with
experimental conditions closely replicating in vivo situations. The overall aim of my
dissertation is to understand the molecular and cellular mechanisms of how shear stress
and nitric oxide (NO) regulate microvessel function under physiological and pathological
conditions. Studies were conducted on individually perfused intact rat mesenteric venules.
It is well known that shear stress is one of most important regulators in stimulating
endothelial cells to produce NO. NO, in addition to being a potent vasodilator, has also
been considered a “double edged sword”-mediator in inflammation. Under basal
conditions, it prevents leukocyte and platelet adhesion, whereas under inflammatory
conditions, the inflammatory mediator-induced excessive NO production contributes to
permeability increases. In Chapter 2, we investigated the roles of endothelial basal NO
production in leukocyte adhesion and adhesion-induced changes in microvessel
permeability. The results indicated that the application of the eNOS specific inhibitor,
caveolin-1 scaffolding peptide (CAV), caused reduction of basal NO and promoted ICAM1-mediated leukocyte adhesion through Src activation-mediated ICAM-1 phosphorylation.
Also, CAV-induced leukocyte adhesion was uncoupled from leukocyte oxidative burst and
microvessel barrier function, unless in the presence of a secondary stimulation.
In Chapter 3, we investigated the roles of shear stress (SS) in the regulation of
microvessel permeability and its related EC signaling involving blood cells in individually
perfused intact microvessels. Our results demonstrated that in response to a sudden
change of SS, transient shear magnitude-dependent increases in EC [Ca2+]i occurred only
in vessels perfused with whole blood or perfusate containing RBCs, which was correlated
with EC gap formation illustrated by fluorescent microsphere accumulation. Carbenoxolone,
a Pannexin 1 inhibitor, significantly reduced shear magnitude-dependent ATP release from
RBCs and also abolished SS-induced increases in EC [Ca2+]i and EC gap formation.
Meanwhile, both plasma and whole blood perfusion induced shear magnitude-dependent
NO production and eNOS-Ser1177 phosphorylation.
It is unknown how EC sense SS, but the Glycocalyx (GCX), a layer of proteoglycans
covering the endothelium, has been implicated as a mechanical sensor for changes in SS
in vitro. The objective of chapter 4 is to identify the changes in GCX in microvessels of
ii

streptozotocin-induced diabetic rats and evaluate the associated changes in sensing SS
and SS-induced NO production in individually perfused venules of diabetic rats. Our results
indicated that the impaired GCX in diabetic microvessels enhances EC response to
mechanical force and potentiates NO production and EC responses to ATP, resulting in
enhanced endothelial gap formation.
Advances in micromanufacturing and microfluidic technologies have enabled a variety
of insights into biomedical sciences while curtailing the high experimental costs and
complexities associated with animals and in vivo studies. In Chapter 5, we presented and
discussed our research work in creating engineered microvessels using a microfluidic
platform and demonstrated the formation of the microvascular network in vitro and validated
the key features that have been observed in microvessels in vivo. In our future studies,
this may provide us a novel platform for studying spatial and temporal change of shear
stress in the regulation of microvessel function in a close in vivo situation.
In conclusion, we revealed the role of shear stress and NO in the regulation of
endothelial cell signaling and microvessel permeability in vivo, involving blood and nonblood components. The results also suggest the potential in using a microfluidic device in
studying the physiological microvessel function.

iii
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CHAPTER 1
LITERATURE REVIEW

INTRODUCTION
The vascular endothelium lining the interior surface of vascular wall maintains vascular
homeostasis by modulating a variety of vascular functions including vascular tone,
angiogenesis, vascular remodeling, and inflammatory responses. As a semi-permeable
barrier, endothelium is particularly important in regulating the vascular permeability by
controlling the exchange of macromolecules and fluid between the blood and interstitial
space. Under physiological conditions, the increased vascular permeability enables the
extravasation of plasma proteins, immunoglobulins, and others, which serves as one of the
important host-defense functions. However, unchecked vascular permeability increase can
lead to protein-rich tissue edema, chronic inflammation, and organ dysfunction.
Atherosclerosis is one of those pathologies. It has been demonstrated in vivo that
atherosclerosis patch is co-localized with sites of elevated endothelial permeability.1, 2
Endothelial dysfunction is well recognized as the initial step in the atherosclerotic
process.3, 4 A major vasoactive substance released by the endothelium is nitric oxide (NO),
originally named as endothelium-derived relaxing factor (EDRF). NO has been recognized
to play a pivotal role in maintaining normal vascular functions. Dysregulated NO production
or eNOS (endothelial NO synthase) activity has been proposed as a major mechanism of
endothelial dysfunction, contributing to atherosclerosis. However, in addition to being a
critical mediator in maintaining vascular homeostasis, NO has also been considered as a
“double edged sword”-mediator in inflammation. It has been reported that excessive NO
production induced by inflammatory mediators contributes to increased microvessel
2

permeability, leading to tissue edema and organ dysfunctions. 5-7 Basal NO production, on
the other hand, has been reported to prevent leukocyte adhesion and platelet aggregation
on the vessel wall, therefore, playing an anti-inflammatory role.8-10 In Chapter 2 of this
dissertation, by using caveolin-1 scaffolding domain peptide, an endothelial nitric oxide
synthase (eNOS) specific inhibitor, we investigated the role of and underlying mechanisms
of endothelial basal NO in preventing leukocyte adhesion and adhesion-induced increases
in microvessels permeability.
Wall shear stress (SS) is the tangential force exerted per unit area of blood-endothelium
surface. Disturbed shear stress has been reported to promote atherosclerosis and
inflammation in the vessel wall.11, 12 Postcapillary venules are the dominant sites for the
occurrence of inflammation and increased microvessel permeability. The role of shear
stress in the regulation of venular microvascular barrier function, and how the endothelium
senses the change of SS under either physiological or pathological, in particular under
diabetic conditions, have not been well explored so far. In Chapters 3 and 4 of this
dissertation, studies were conducted to understand the cellular and molecular mechanisms
of how SS regulates microvascular barrier function under physiological and diabetic
conditions in intact microvessels. In Chapter 3, we investigated the mechanisms of SSinduced changes in microvessel permeability under physiological conditions. We proposed
that the glycocalyx on the endothelial surfaces acts as a mechanical sensor of SS to cause
alterations in EC [Ca2+]i, and NO, thus contributing SS-induced changes microvessel
permeability. In this study, we measured EC NO, [Ca2+]i changes and microvessel
3

permeability in response to quantitative alterations of SS in intact rat mesenteric venules.
The glycocalyx has been implicated as a mechanical sensor of changes in SS. A variety of
diseases such as endotoxemia and hyperglycemia have been reported to cause damage
to the glycocalyx coating on the EC surface.13, 14 However, little is known about the potential
effect of degraded glycocalyx on SS-mediated vascular function and how the altered
vascular function playing a role in the pathogenesis of these diseases. Therefore, in
Chapter 4, studies were conducted to investigate the role of impaired glycocalyx
(mechanosensor) in microvessel barrier dysfunction in diabetes by evaluating the
ultrastructural changes of EC glycocalyx in the vascular wall and the correlated alterations
in SS-induced EC signaling, as well as microvessel permeability using fluorescence and
electron microscopic approaches.
To investigate the effects of spatial and temporal variations of SS on endothelial
vascular function is a big challenge for us in our study. In vivo microvasculature has
unbelievably heterogeneous and complex geometries. It is difficult for us to define and find
a certain angle of bifurcated segments in each experiment. Also, due to the time limitation
of the in vivo experiments, it is difficult for us to observe the effect of long term SS on
endothelial cell signaling and morphological changes, which usually requires more than 48
hours shear exposure. Fortunately, by using up-to-date microfluidic devices lined with
primary human umbilical vein endothelial cell, which recapitulated microvessels with fixed
geometric pattern, we successfully investigated the long term SS effect on endothelial cell
morphology, and how the changes in morphology is associated with changes in cellular
4

signaling. In Chapter 5, we investigated changes in vascular endothelial F-actin and VEcadherin to different levels of SS. Also, we quantitatively measured changes in EC [Ca2+]i
and NO production to adenosine triphosphate (ATP).
In summary, the dissertation mainly focuses on investigating the mechanisms of shear
stress-mediated changes in microvascular permeability in vivo and in vitro, involving blood
and non-blood components

5

BACKGROUND AND SIGNIFICANCE
MICROVESSEL PERMEABILITY
General aspect
Under physiological conditions, the semi-permeable property of vascular wall
enables the exchange of gases, ions, and solutes across the vessel wall through
endothelial transport. In general, endothelial transport can be divided into paracellular and
transcellular pathways. Passive diffusion through the endothelial paracellular route has
been found as a dominant exchange pathway for fluid and hydrophilic solutes with
molecular radii of up to 3 nm.15 On the other hand, the transcellular vesicular pathway is
responsible for the active transport of macromolecules, such as albumin. In order to
quantitatively define the microvessel exchange property, microvessel permeability
coefficients, which reflect and represent the barrier function of microvascular walls to a
specific substance, were adopted in various experimental measurements as shown in
Table 1.
Table 1 Membrane permeability coefficients
Permeability coefficient
Hydraulic conductivity
Diffusional permeability
Solvent drag (ultrafiltration)
Osmotic reflection coefficient

Symbol
Lp
Pd
σf
σd

In the studies of this dissertation, the hydraulic conductivity (Lp), which represents the fluid
permeability across the vessel wall was evaluated in individually cannulated intact venules.
The Lp was quantitatively measured by calculating the volume flux of water across the

6

vessel wall under a certain driving force of pressure difference. It is well illustrated in the
Starling Equation. 16
Jv = (LpS)[(Pc – Pi) – σ(πc – πi)]

Jv: Volume flux of fluid; Lp: Hydraulic conductivity; S: Surface area; Pc:Capillary fluid
hydrostatic pressures; Pi: Interstitial fluid hydrostatic pressures; πc: Capillary colloid osmotic
(oncotic) pressures; πt:Interstitial colloid osmotic (oncotic) pressures; σ:Osmotic reflection
coefficient of vessel wall (0 if membrane is fully permeable to transported molecular species
and 1 if the membrane is impermeable).
Various experimental preparations in measuring permeability coefficients
Microvascular permeability coefficients can be measured from perfused whole
organs, single cannulated microvessels, to monolayers of cultured endothelial cells. They
all have their advantages and disadvantages.
Permeability coefficient measured in whole organs, isolated tissues or whole animals,
involves minimal interference with experimental handling, which is closest to the native
situation in vivo. However, those studies usually overlook changes in transmural pressure
gradients, changes in exchanging surface area, and presence of blood cells in the
regulation of vascular permeability. Especially, in those animal disease models, the
changes of cell and vascular morphology can greatly affect hemodynamic alternation,
which usually results in inconclusive measurements.
The use of in vitro monolayers of cultured ECs allows the investigation of cellular and
molecular mechanisms of the regulation of endothelial permeability. However, cultured
7

endothelium has been reported to be a pro-inflammatory endothelial phenotype in
comparison to the native endothelium in vivo.

17

Also, multidimensional protein

identification revealed that 41% of proteins expressed in vivo were not detected in vitro,
indicating that distinct in vivo protein expression is apparently regulated by the tissue
microenvironment and cannot yet be duplicated in standard cell culture.18 It raises serious
concerns when directly applying the knowledge we gained from in vitro to those in vivo.
Using a single cannulated microvessel in the study of microvessel permeability is the
main technique we adopted in this dissertation. The primary advantages of this approach
is that it allows the direct and precise control of the conditions of perfusion for a defined
segment of microvessel while directly measuring the real time changes of the vessel
surface area, the difference in pressure, and concentration of solutes across the vessel
walls. The limitations of studies on single vessels are i) experimental preparations are
restricted to several convenient vessel types, such as mesenteric vessels and cremaster
vessels; ii) there is an experimental duration limit for these preparations and iii) each
experiment preparation is also quite time consuming.
NITRIC OXIDE (NO), MICROVESSEL PERMEABILITY & LEUKOCYTE ADHESION
NO has been recognized as an important cardiovascular signaling factor that is not
only a potent vasodilator regulating vascular tone and blood pressure, but also plays an
important role in the regulation of microvessel permeability and leukocyte adhesion.
22

8, 19-

NO is biosynthesized from L-arginine through the enzyme NO synthase (NOS). There

are three main isoforms of the enzyme called neuronal NOS (nNOS), inducible NOS
8

(iNOS), and endothelial NOS (eNOS). Among those, eNOS has been found to be the
dominant constitutive enzyme responsible for NO production in the cardiovascular system.
NO and microvessel permeability
For decades, a growing body of literature suggested that NO modulates the
movement of fluid and protein from the vasculature. However, the results obtained from
whole organ, single vessel, and endothelial monolayer studies are often not consistent.
Numerous experimental evidence suggest that endogenous NO increases microvascular
permeability while an equal amount of evidence indicates that NO inhibits increases in
microvascular permeability. Since the early 1990s, Kubes et al. and others showed that
nonselective NO synthase inhibition increased vascular leakage in the presence of blood,
suggesting a protective role of NO in barrier function.

8, 23-25

Almost at the same time,

others showed that inhibition of NO prevented permeability increases in response to
inflammatory mediators and other physical stimulates.7, 22, 26-35 Those conflicting results
were derived from different experimental approaches, organs, tissue conditions, and
animal species. Our previous findings showed that excessive NO production induced by
inflammatory stimuli is responsible for the increases in microvessel permeability 26-29. Our
present study in this dissertation was to investigate the role of basal NO production in the
regulation of microvessel permeability using the same experimental preparation.
Combined, these two results revealed the dual actions of NO on endothelial functions at
basal and inflammatory conditions, which provides a unified perspective of the roles of NO
in the regulation of endothelial function and microvessel permeability.
9

Caveolin-1, the primary coating protein of caveolae, has been recognized as a key
regulator of eNOS activation through binding of its "scaffolding domain". In Chapter 2, by
using a chimeric peptide with a cellular internalization sequence (homeodomain of
antennapedia (AP) fused to the caveolin-1 scaffolding domain (amino acids 82−101),
which we named as AP-CAV, we were able to specifically inhibit eNOS and its basal NO
production. Our results suggested that the reduced basal NO did not directly increase
microvessel permeability. It is consistent with results from eNOS knockout mice that basal
permeability is not affected by the absence of eNOS.36
NO and leukocyte adhesion
Before we discuss the role of NO in leukocyte adhesion, it is important to briefly review
the process of the recruitment of leukocytes into inflamed tissues. The adhesion of
leukocytes to vascular endothelium is one of the most dramatic cellular responses of the
inflammatory process. The recruitment process has been intensively investigated and
characterized into several main steps. This recruitment process requires specific adhesion
glycoproteins in the interaction of leukocytes with ECs. Initially, leukocytes marginate to the
vascular wall due to both physical and chemical factors, such as piled up red blood cells
behind leukocytes and the secretion of chemokines.37, 38 Then the leukocytes start to roll
and tether in a process involving a group of selectin family proteins, such as L-selectin at
the surface of leukocytes, and E-selectin and P-selectin expressed on activated ECs.

39

After cytokines activate both leukocytes and endothelium, leukocytes get into a stationary
state in which the leukocyte remains firmly attached to the endothelial cell surface, without
rotational motion. This is mediated by the CD11/CD18 on the leukocytes and ICAM-1 or
10

VCAM-1 on the ECs.19 Following the firm adhesion, leukocytes may transmigrate from
postcapillary venules into the interstitial space through a paracellular or transcellular route,
a process involves PECAM-1 and ICAM-1.38
Studies performed in various in vitro or animal models have shown the role of NO in
anti-leukocyte adhesion. This was supported by the facts that non-specific NOS inhibitors,
such as NG-Monomethyl-L-arginine (L-NMMA) or NG-nitro-L-arginine methyl ester (LNAME), evoked marked increases in the attachment of leukocytes to endothelial cells. 9, 4042.

Also, it has been shown that NO donors (nitroprusside, SIN-I) and superoxide dismutase

attenuate or prevent the leukocyte adherence induced by different inflammatory stimuli.43
Although it is well known that leukocyte-endothelial interaction is dependent on the
expression or activity of adhesion molecules, the role of NO in regulating those molecules
has not been fully elucidated. In vivo studies on cats and rats suggested that giving LNMMA or L-NAME systemically causes the increase of CD11/CD18 complex expression
on leukocytes 9, 41, 44. It was also shown that superfusion of the rat mesentery with L-NAME
significantly increased leukocyte rolling and adherence in mesenteric venules through
enhanced the expression of P-selectin.45 In addition, in vitro studies indicated that the antiadhesive role of NO could also be attributed by changing the expression or activity of ICAM1 and VCAM-1.46, 47 However, those observations are not consistent with each other due
to different animal species, tissue origins and experimental preparations.
In Chapter 2, we found that perfusion of AP-CAV in rat postcapillary venules, not only
inhibited the basal NO production, it also increased adhesive binding sites of ICAM-1 for
leukocyte adhesion. Moreover, we showed significant increases in phospho-(Y526)-ICAM11

1 staining following AP-CAV perfusion, which was abolished by a Src kinase inhibitor, PP1.
Consistent with our findings, overexpression of caveolin-1 was shown to reduce NO
production in vitro 48-50, and eNOS-deficient mice showed an increased number of adherent
leukocytes.

51

These results demonstrated that the reduced basal NO does not directly

increase permeability, but rather primes the microvascular endothelial cells into an
adhesive state.
SHEAR STRESS AND MICROVESSEL PERMEABILITY
Blood flow-generated hemodynamic forces are the most physiologically relevant factors
for the maintenance and regulation of the homeostasis of endothelial cells. Hemodynamic
forces can be divided into two major vectors which are tensile stress (pressure) and SS.
The stress perpendicular to the vessel wall is defined as tensile stress, which imposes
circumferential stretch to the tissue. The stress parallel to the vessel wall is defined as SS,
which serves as frictional force acting on the surface of endothelial cells. There has been
substantial evidence that early atherosclerotic plaques develop mainly in regions of low wall
SS, such as arterial bifurcations, whereas vascular regions with high laminar wall SS are
less prone to develop atherosclerotic plaques.11, 52 Disrupted endothelial function, including
vascular barrier dysfunction, have been considered as the major causes of
atherosclerosis.3, 53 Thus, it is essential to study how SS regulates the endothelial cell
signaling and related vascular barrier function.
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Shear stress and NO production
Although there is a large body of studies trying to elucidate how SS induce EC to
generate NO, the knowledge of SS-induced NO production still remains unclear. Firstly,
due to low concentration and short half-life of NO, it is difficult to accurately measure it in
real time. In addition, it is particularly challenging in detecting NO produced in response to
shear stress due to changes in flow caused other changes such as chemical degradation.
Several direct and indirect techniques have been established to measure NO. Indirect
methods involve measurement of nitrite or nitrate (the end product of NO metabolism) using
the Griess reagent, 54 detecting soluble guanylyl cyclase (sGC) (which is activated after NO
binding) using chemiluminescence methods,

55

and measurement of cGMP, which is

produced by activated sGC, using a sGC derived fluorescence indicator.

56

Direct

measurement of NO includes electrodes and 4’,5’-diaminofluorescein diacetate (DAF-2
DA), a cell permeable fluorescent probe. Up to now, electrodes remain the dominant
method for direct NO measurement. However, since NO has a sharply decreased gradient
in concentration away from the source of production, the precise and reproducible
positioning of the electrode becomes a critical limiting factor in this method. In Chapter 3,
we used DAF-2 as a NO indicator to directly measure the NO production induced by flow
shear stress. The drawback of this dye is its relative short maintaining time (about 1 to 1.5
hrs) inside the cells in vivo. Secondly, prior in vitro studies on the role of Ca2+ in shear
stress-mediated NO production have yielded conflicting results. Some studies suggested
that the increase in NO production was independent of extracellular Ca2+, suggesting the
release of Ca2+ from intracellular stores as an important source responsible for the
13

increased EC [Ca2+]i.57, 58,59 However, other studies suggested that removal of extracellular
Ca2+ blocked flow-induced NO release from intact vessels and from cultured endothelial
cells. 60 Also, for those cells grown on collagen-coated microcarrier beads, either removal
of medium Ca2+ by using EGTA or chelation of intracellular Ca2+ by adding BAPTA did not
block flow-mediated NO release.

61

Those varied results may be due to the difference in

cultured cell origins, variable concentrations of ATP in culture media, and different
conditions of flow (laminar or turbulence flow). Our results demonstrated that the changes
of wall SS generated by perfusion of microvessels with either blood or plasma, induced NO
production in vivo. Additionally, only blood perfusion induced transient increase in EC
[Ca2+]i, suggesting that wall shear stress induced NO production may be calcium
independent.
Shear stress and EC [Ca2+]i changes
Ca2+ is a major internal cell signaling component. It mediates a large range of cell
functions such as cytoskeleton reorganization, apoptosis and contraction. A number of
studies from different research groups have demonstrated a link between pro-inflammatory
mediator-induced Ca2+ signaling and endothelial permeability.62-65 It has been shown that
inhibition of Ca2+ influx and depletion of the extracellular Ca2+ abolished or significantly
attenuated the inflammatory stimuli-induced increase in microvessel permeability.

62, 65

These results indicate that the increase in EC [Ca2+]i is an essential signal for inflammatory
mediator-induced increases in microvessel permeability. It is proposed that blood flowgenerated SS modulates endothelial calcium response via two pathways under
physiological condition.66 Firstly, SS enhances the transfer of blood-borne agonists, e.g.
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those inflammatory stimuli, to the endothelial cell surface, which mediates the increase of
EC [Ca2+]i . Secondly, the permeability of the cell membrane to extracellular calcium
increases upon pure exposure to SS. The increase of EC [Ca2+]i induced by the change in
SS was thought to be mainly due to the influx of extracellular Ca2+ across the cell
membrane, which is elicited by the disappearance of Ca2+ response to SS after the removal
of extracellular Ca2+. 67 However, it has been controversial for decades whether exposure
of EC to flow itself is accompanied by elevated cytoplasmic calcium concentration.57, 68, 69
In those studies, the acute change of SS induced varied magnitude of increase in [Ca2+]i,
and the effects were not related to the magnitude of the SS.68, 69 One of the main differences
for the inconsistent observations in those studies is the amount of ATP in culture cell
medium.69, 70 It has been shown that in the absence or a low concentration of ATP, the
change of EC [Ca2+]i in response to the change of SS is not significant or weak.67, 69, 71 In
Chapter 3, we showed that only blood flow-generated sudden changes in SS, but not
plasma or similar viscous dextran-albumin-ringer fluid perfusion, induced a transient EC
[Ca2+]i increase in a shear-magnitude-dependent manner. More interestingly, the shearinduced ATP release from red blood cells contributes to the transient mobilization of EC
[Ca2+]i.
Shear-dependent permeability examined in vitro
The development of different types of flow devices and successful lining of cultured
endothelial monolayers on the test surfaces enables the investigation of the relationships
between SS and the endothelial function in vitro. Up to now, there are four types of flow
devices used to define SS: 1) parallel-disk viscometer; 2) the cone and plate viscometer;
15

3) parallel plate flow chamber; and 4) microfluidic device. Easy access to the cells and
ready manipulation of the ﬂow characteristics provided a great amount of information in
understanding how cell response to the SS from changes in gene expression, cell signaling,
to cell morphology and function. It has been shown on Bovine Aortic Endothelial Cells
(BAEC) and Human Umbilical Vein Endothelial Cells (HUVEC) monolayers that flow SS
can increase Lp and electrical impedance mediated by NO.

72-75

Meanwhile, those two

types of cells have different magnitude and duration of permeability increase in response
to SS. The diverse responses to SS in different cell types may due to their difference in
intracellular signaling pathways and transport properties.76 Although in vitro studies provide
us valuable insights into potential mechanisms involved in the regulation of SS-mediated
changes in endothelial permeability, whether it can reflect the truth in vivo is still a question.
In fact, there are several significant differences between the cultured cell and in vivo
situation. Firstly, most of the in vitro studies were conducted with cells grown under static
conditions, and then exposed to SS during measurements. Thus, the observed response
has been doubted as the adaptation to a changed SS environment rather than a direct
effect of fluid SS on endothelium functions. Secondly, cultured cells have a proinflammatory
phenotype. Its basal permeability is ~10 fold higher than that in intact venules.77 Thirdly,
most in vitro studies did not include blood cells components in generating SS, which differs
from the in vivo situation where SS is generated by blood flow.
Shear-dependent permeability examined in vivo
Post-capillary venules are the main sites where the permeability increase and
recruitment of leukocytes occur during inflammation. Acute responses to changes in shear
16

stress have its physiological significance in monitoring changes in activity level or the
demands to a specific organ on a minute-to-minute basis.78 Kajimura and Michel showed
a positive correlation between flow velocity and potassium ion permeability in rats venules.
79

Also, Montermini et al. demonstrated sodium fluorescein permeability increases linearly

to flow velocity in both rat and frog venules. 78 However, although there were a few in vivo
studies which investigated whether the shear stress (by increasing either perfusion
pressure or shear rate) affect microvessel Lp in frog or rat mesentery venules, the clear
pictures regarding how shear regulates the microvessel barrier function still remain
controversial. 80-82 By using a double cannulation method, Neal and Bates could not find a
positive correlation between increased flow rate and Lp in microvessels of frog
mesentery.80 Using modified Landis technique, Adamson et al. did not observe a correlation
between shear stress and Lp in vessels perfused in the orthograde direction.82 Conversely,
using the same technique, Williams showed a dramatic increase in Lp in response to a step
change in shear stress in rat venules.83 In addition, Kim et al. observed that changes in Lp
were positively correlated with the magnitude of acute changes in shear stress in
autoperfused microvessels.84 The controversy of those studies may due to the differences
in methods, (e.g. single or double cannulation, and autoperfusion), as well as the difference
in the nature of the perfusate (e.g. in the presence or absence of blood cells). In this study,
we investigated the precise role of blood or non-blood flow-generated acute increase of
wall shear stress on endothelial cell signaling and microvessel permeability.
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Impaired glycocalyx (shear stress mechanosensor) in disease model
Although a vast number of studies have been undertaken to investigate the
mechanisms of shear stress-mediated mechanotransduction, the mechanosensor and
sensing signaling, which recognizes shear stress and passes the mechanical force into
intracellular signaling pathway have not been identified. So far, there are several
mechanosensor candidates have been proposed on the surface of EC, such as ion
channels,85 G-protein-coupled receptors (GPCRs), 86 caveolae, 87 adhesion proteins,88 and
the glycocalyx.89
The glycocalyx is an organized negatively charged mesh of glycoproteins,
proteoglycans, glycosaminoglycans (GAGs), and associated plasma proteins of
proteoglycans covering the endothelium. Involvement of the glycocalyx in EC responses to
shear stress has been demonstrated by enzymatic removal Heparan Sulfate using
heparinase III on BAEC completely inhibited NO production induced by fluid shear stress.
90

However, the glycocalyx in cultured cells is considerably thinner than that in intact

venules.91 Therefore, it is important to investigate the roles of the glycocalyx in shear stressmediated endothelium functions in intact microvessels.
Besides its function as a mechanosensor, glycocalyx serves throughout the vasculature
as an aegis, protecting blood vessels from coagulation, inflammation and atherosclerosis.
Decreased glycocalyx volume has been reported in diabetic patients.14 A study in frog
microvessels showed an increased microvessel hydraulic conductivity (Lp) upon partial
digestion of the endothelial glycocalyx.92 Our previous study found an increased basal
permeability and enhanced permeability responses to inflammatory mediators in venules
18

of streptozotocin-induced diabetic diabetic rats.93 Whether the increased permeability in
diabetic rats is a result of an impaired glycocalyx remains unknown. In Chapter 4, we
conducted experiments to test the hypothesis that hyperglycemia-induced damages to the
glycocalyx contribute to the increases in microvessel permeability in diabetic rats. Also, we
investigated the effect of impaired glycocalyx on changes in shear stress-induced nitric
oxide (NO) production in individually perfused venules of diabetic rats.
ENDOTHELIALIZED MICROFLUDIC DEVICE – MINIATURIZED FUNCTIONAL
MICROVESSELS
The idea of using microfluidic devices as miniaturized whole organ or tissue is much the
same way as a microelectronic circuit is an entire computer on a chip. Since the idea came
out, microfluidic technology has given great promise to overcome the challenge of
performing in vitro experiments with more physiologically realistic setups but still easier and
cheaper to handling than animal studies. In Chapter 5, in vitro growth microvessel network
using the microfluidic approach and characterized the ECs’ junction, responses to shear
stresses, NO production, and endothelial [Ca2+]i. The results demonstrated that the model
successfully recapitulates key aspects and functions of the in vivo microvessels.

19

OBJECTIVES
Specific Aim 1 to investigate the roles of exogenously applied CAV in endothelial basal
NO production, leukocyte adhesion, and adhesion-induced changes in microvessel
permeability.
Specific Aim 2 is to investigate the cellular and molecular mechanisms for how shear
stress regulates microvessel functions under physiological conditions.
Specific Aim 3 is to investigate the role of impaired glycocalyx in microvessel barrier
dysfunction in diabetes.
Specific Aim 4 is to demonstrate in vitro formation of microvessels that recapitulate key
features of the microvessels in vivo.
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CHAPTER 2
CAVEOLIN-1 SCAFFOLDING DOMAIN PROMOTES LEUKOCYTE ADHESION BY
REDUCED BASAL ENDOTHELIAL NITRIC OXIDE-MEDIATED ICAM-1
PHOSPHORYLATION IN RAT MESENTERIC VENULES
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ABSTRACT
Exogenously applied caveolin-1 scaffolding domain (CAV) has been shown to inhibit
inflammatory mediator-induced nitric oxide (NO) production and NO-mediated increases in
microvessel permeability. However, the effect of CAV on endothelial basal NO that
prevents leukocyte adhesion remains unknown. This study aims to investigate the roles of
exogenously applied CAV in endothelial basal NO production, leukocyte adhesion, and
adhesion-induced changes in microvessel permeability. Experiments were conducted in
individually perfused rat mesenteric venules. Microvessel permeability was determined by
measuring hydraulic conductivity (Lp). NO was quantified with fluorescence imaging in
DAF-2-loaded vessels. Perfusing venules with CAV inhibited basal NO production without
affecting basal Lp. Resuming blood flow in CAV perfused vessels significantly increased
leukocyte adhesion. The firmly adherent leukocytes altered neither basal Lp, nor adherens
junction integrity. Increases in Lp occurred only upon formyl-Met-Leu-Phe application that
induces release of reactive oxygen species from the adherent leukocytes. The application
of NO synthase inhibitor showed similar results to CAV, and NO donor abolished CAVmediated leukocyte adhesion. Immunofluorescence staining showed increases in binding
of ICAM-1 to an adhesion-blocking antibody concurrent with a Src-dependent ICAM-1
phosphorylation following CAV perfusion. Pre-perfusing vessels with anti-ICAM-1 blocking
antibody or a Src kinase inhibitor attenuated CAV-induced leukocyte adhesion. These
results indicate that the application of CAV, in addition to preventing excessive NOmediated permeability increases, also causes reduction of basal NO and promotes ICAM1-mediated leukocyte adhesion through Src activation-mediated ICAM-1 phosphorylation.
CAV-induced leukocyte adhesion was uncoupled from leukocyte oxidative burst and
microvessel barrier function, unless in the presence of a secondary stimulation.
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INTRODUCTION
Nitric oxide (NO), in addition to being a potent vasodilator, has also been considered a
“double edged sword”-mediator in inflammation. Excessive NO production induced by
inflammatory mediators contributes to an increase in microvessel permeability and plays a
pro-inflammatory role.

1-3

Constitutive (or basal) NO production, on the other hand, has

been reported to prevent leukocyte adhesion and platelet aggregation on the vessel wall,
therefore, playing an anti-inflammatory role. 4-6
Caveolin-1, the major structural protein in the caveolae of endothelial cells, is a
recognized endogenous inhibitor of endothelial nitric oxide synthase (eNOS).

7, 8

The

discovery of the scaffolding domain of caveolin-1 (CAV) that directly interacts with eNOS,
and the use of Antennapedia homeodomain (AP) fusions to facilitate CAV uptake by living
cells, provided a valuable tool for investigating the mechanisms involved in the regulation
of eNOS activity through protein-protein interaction and NO-dependent vascular functions
in vivo. Our previous studies demonstrated that exogenously applying AP-CAV to a
perfused intact microvessel inhibits platelet activating factor (PAF)-induced NO production
and NO-mediated increases in microvessel permeability.

9, 10

In whole animal studies, the

administration of AP-CAV suppressed tissue edema and vascular leakage.

11

These

studies suggest an anti-inflammatory therapeutic potential for AP-CAV. However, whether
the exogenously applied caveolin-1 peptide affects basal endothelial NO production has
not been studied. If AP-CAV inhibits basal NO, whether it causes leukocyte adhesion and
increases microvessel permeability is unknown. This study directly addresses these
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questions by measuring basal NO, microvessel permeability, and leukocyte adhesion in
AP-CAV-perfused intact microvessels.
Experiments were conducted in individually perfused venular microvessels in rat
mesenteries. We first quantitatively measured the effect of AP-CAV on endothelial basal
NO production with DAF-2 using fluorescence imaging. We then examined the effect of
AP-CAV on leukocyte adhesion, the mechanisms involved in the increases in adhesive
activity of endothelial cells, and their impact on microvessel permeability. Permeability was
determined by measuring hydraulic conductivity (Lp). The changes in endothelial junction
integrity and adhesive capacity of adhesion molecules were evaluated by confocal imaging
of immunofluorescence staining on AP-CAV-perfused microvessels.
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METHODS
Animal preparation
Experiments were carried out on venular microvessels in rat mesenteries. All procedures
and animal use were approved by the Animal Care and Use Committee at West Virginia
University. Female Sprague-Dawley rats (2–3-mo old; body wt 220–250 g; Hilltop Laboratory
Animals; Scottdale, PA) were anesthetized with pentobarbital sodium given subcutaneously.
The initial dosage was 65 mg/kg of body weight with an additional 3 mg dose given as
needed. The trachea was intubated, and a midline surgical incision (1.5–2 cm) was made in
the abdominal wall. The mesentery was gently moved out of the abdominal cavity and spread
over a glass cover slip attached to an animal tray. The upper surface of the mesentery was
continuously superfused with mammalian Ringer solution. The temperature of the
superfusate was maintained at 37°C. All experiments were carried out on venular
microvessels with diameters ranging between 40 and 50 μm. Each experiment was
performed on a single microvessel with one experiment per animal.
Measurement of Lp in individually perfused rat mesenteric microvessels
Modified Landis technique was used to measure the volume flux of water across the
microvessel wall. The methods have been evaluated in detail.

12, 13

In brief, a single

microvessel was cannulated with a micropipette and perfused with albumin-Ringer solution
(control) containing 1% (vol/vol) hamster red blood cells as markers. A hydrostatic pressure
(range 40–60 cmH2O) was applied through the micropipette to the microvessel lumen to
maintain a continuous flow. Water flux was measured when the vessel was briefly occluded
downstream. Lp was calculated as the slope of the relationship between the initial water flux
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per unit area of microvessel wall and the pressure difference across the microvessel wall. In
each experiment, the baseline Lp and the Lp after application of testing solutions were
measured in the same vessel and the changes in Lp were expressed as the ratio of Lptest /
Lpcontrol
Fluorescence imaging of endothelial nitric oxide production
Endothelial NO production was measured on DAF-2 DA loaded vessels using
fluorescence imaging. Experiments were performed on a Nikon Diaphod 300 microscope
equipped with a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled
shutter (Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as
the light source. The excitation wavelength for DAF-2 was selected by an interference filter
(480/40 nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass
barrier (535/50 nM). All the images were acquired and analyzed using Metafluor software
(Universal Imaging). To minimize the photo-bleaching, a neutral density filter (0.5 ND) was
positioned in front of the interference filter and the exposure time was minimized to 0.12
sec at 1 min intervals.
During the experiments, each vessel was cannulated and perfused with albumin-Ringer
solution containing DAF-2 DA (5 µM) throughout the experimental duration. Image
collection was started at the beginning of DAF-2 DA perfusion. All images were collected
from a group of endothelial cells located in the same focal plane of the vessel wall using a
Nikon Fluor lens (x20, numerical aperture, 0.75). A steady-state of endothelial DAF-2
fluorescence (FIDAF) with continuous perfusion of DAF-2 DA was indicated by the rate
change of the increased FI. Quantitative analysis was conducted at the individual
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endothelial cell level using selected regions of interest (ROIs) along the vessel wall. Each
ROI covers the area of one individual cell as indicated by the fluorescence outline. The
tissue autofluorescence was subtracted from all of the measured FIs. The basal NO
production rate was calculated from the slope of the FIDAF increase during albumin-Ringer
perfusion after DAF-2 loading reached the steady-state. FIDAF was expressed in arbitrary
units (AU). The rate of FIDAF increase (df /dt) derived by first differential conversion of
cumulative FIDAF over time indicates the rate of NO production. Details have been
described. 14
Immunofluorescence staining and confocal imaging
VE-cadherin and adherent leukocyte staining was conducted in vessels after CAVinduced leukocyte adhesion. Phosphorylated ICAM-1 at Y526 staining was conducted in
vessels after 30 min AP-CAV perfusion in the presence or absence of the Src kinase
inhibitor, PP1. The rat mesentery bearing the perfused vessel was fixed with 1%
paraformaldehyde and treated with triton X-100 before exposure to primary antibodies
against VE-cadherin (C-19, sc-6458, Santa Cruz Biotechnology) and CD45 (clone OX-1,
Biolegend), or phospho-(Y526)-ICAM-1 (ab51033, Abcam) and followed by incubation with
their corresponding secondary antibodies (Invitrogen).
ICAM-1 staining was conducted in intact microvessels. Each venule was first perfused
with albumin-Ringer solution for 10 min and then perfused with ICAM-1 primary antibodies
(1A29 BD Pharmingen, 0.1 mg/ml) for 20 min. The secondary antibody (Invitrogen) was
applied to each vessel for 15 min after washout of the primary antibody from the vessel
lumen. Nuclei were labeled by perfusion vessels with DRAQ5 (Biostatus). The confocal
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images were acquired after all of the fluorescence markers were washed out from the
vessel lumen.
All of the images were acquired using Leica confocal microscope. Each image stack
was collected by optical sectioning at successive X-Y focal planes with a vertical depth of
0.3 µm (phospho-(Y526)-ICAM-1) and 0.5 µm (ICAM-1) using Leica X25 objective (HC
Plan APO, NA 0.95) and 1024 x 1024 scanning format. Leica software was used for image
acquisition and image analysis.
The fluorescence intensity (FI) of labeled ICAM-1 and phospho-(Y526)-ICAM-1 was
quantified from a segment of the vessel wall. The total FI was calculated as area × depth ×
mean amplitude, where the area is the selected ROI per vessel section and the depth is
the total number of images at z dimension. Because ICAM-1 was expressed on endothelial
cell surface, FI was quantified as total intensity per square micrometer of vessel wall (FI/A).
Assuming a cylindrical geometry, surface area of the vessel wall was calculated as 2π × r
× L, where r is the radius of the microvessel and L is the length of selected ROI from the
vessel.
Solutions and reagents
Mammalian Ringer solution

15

was used for the experiments. All perfusates contained

albumin-Ringer solution (BSA, 10 mg/ml). AP-CAV, the fusion peptide of caveolin-1
scaffolding domain with AP, the Antennapedia internalization sequence from Drosophila
Antennapedia homeodomain, and AP-CAV-X, the fusion peptide of scrambled CAV with
AP were synthesized by Tufts University. 11 The chemotactic peptide formyl-Met-Leu-PheOH (fMLP) was purchased from Calbiochem (San Diego, CA). PP1 (4-amino-5-(438

methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine), sodium nitroprusside and N(omega)monomethyl-l-arginine (L-NMMA) were purchased from Sigma (St. Louis, MO). The stock
solutions were prepared with 100% DMSO and each final solution was achieved by
>1:1,000 dilution with albumin-Ringer solution.
Data analysis and statistics
All values are mean ± SE. Paired t-test was used for paired data analysis. ANOVA was
used to compare data between groups. A probability value of P < 0.05 was considered
statistically significant.
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RESULTS
AP-CAV inhibits basal NO production without affecting basal Lp in intact venules
The effect of AP-CAV on basal NO was examined in four vessels. A steady-state of DAF2 fluorescence intensity, FIDAF, was reached at 39.5 ± 1.3 min with continuous DAF-2 DA
perfusion. The FIDAF accumulation rate, an indication of basal NO production rate, was 0.13
± 0.01 AU per min. After perfusion of each vessel with AP-CAV (10 µM), FIDAF accumulation
rate significantly decreased to 0.02 ± 0.01 AU per min within 1 min (P < 0.01). To confirm
that DAF-2 was still functional after the application of AP-CAV, a NO donor, SNP (10 µM)
was added to the perfusate in the presence of AP-CAV in two of the vessels. The FIDAF
increased at a relatively linear rate of 0.15 ± 0.01 AU per min, which is comparable with
that under control conditions (Fig. 1A and 1C). Based on these results we estimate that the
level of NO generated by 10 µM SNP is close to basal NO production rate. To compare the
inhibitory effect of AP-CAV on basal NO with that of the NOS inhibitor, basal NO production
was measured in another eight vessels in the absence or presence of L-NMMA (500 µM,
four vessels per group). The mean FIDAF accumulation rate of four vessels was 0.13 ± 0.02
AU per min and was significantly decreased to 0.01 ± 0.002 AU per min in the presence of
L-NMMA (Fig. 1B and 1C), demonstrating a similar magnitude of basal NO reduction to
that of AP-CAV.
To examine whether reduced basal NO via perfusion of AP-CAV has a direct effect on
basal permeability, we measured Lp in four microvessels. The mean baseline Lp of the four
vessels was 1.8 ± 0.2×10-7 cm·s-1·cmH2O-1. After perfusing vessels with AP-CAV (10 μM)
for 30 min, the mean Lp was 1.8 ± 0.3 ×10-7 cm·s-1·cmH2O-1, not significantly different from

40

that of the control. Fig. 2 shows a single experiment and the data summary. Our previous
study demonstrated that perfusion of mesenteric venules with AP-CAV at 1 µM for 30 min
also did not affect basal Lp. 9
AP-CAV perfusion induces leukocyte adhesion without increasing microvessel
permeability unless in the presence of a secondary stimulation.
The effect of AP-CAV-induced basal NO reduction on leukocyte adhesion was
examined in 8 microvessels. Each vessel was perfused with 1 or 10 μM of AP-CAV for 30
min followed by resuming blood flow in the perfused microvessel for 10 min. When each
vessel was re-cannulated with albumin-Ringer perfusate, we observed a dose-dependent
leukocyte adhesion. In vessels perfused with AP-CAV at 1 μM, the adherent leukocytes
increased from baseline levels of 0.7 ± 0.1 to 8.4 ± 0.1 per 100 μm of vessel length (n = 3,
p < 0.05). In 10 μM AP-CAV-perfused vessels, the mean adherent leukocytes increased
from baseline levels of 1.3 ± 0.2 to 26.3 ± 3.2 per 100 μm of vessel length (n = 5). The left
panel of Fig. 3A demonstrates the representative images of leukocyte adhesion before and
after AP-CAV (10 μM) perfusion followed by resumed blood flow from a single vessel. When
Lp was measured in the presence of CAV-induced adherent leukocytes, the mean value
was 2.1 ± 0.1 × 10-7cm·s-1·cmH2O-1, which was not significantly different from the mean
baseline Lp, 1.7 ± 0.2 ×10-7 cm·s-1·cmH2O-1.
Our previous study showed that formyl-Met-Leu-Phe (fMLP) can stimulate reactive
oxygen species (ROS) release from TNF-α-induced adherent leukocytes, resulting in
increases in microvessel Lp.

16

Here, we further investigated whether exposing CAV-

induced adherent leukocytes to fMLP increases Lp. We added fMLP (10 μM) to the
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perfusate after leukocyte adhesion in AP-CAV perfused vessels. To maximize the local
concentration of ROS released from the adherent leukocytes upon fMLP stimulation, the
perfusate was kept at a balanced pressure (no flow) for 5 min before Lp measurement. Lp
measured after 5 min stationary flow transiently increased to mean peak values of 4.8 ±
0.6 and 16.3 ± 2.1 times that of the control in 1 and 10 μM AP-CAV perfused vessels,
respectively. The 5 min stationary flow in the absence of adherent leukocytes does not
affect Lp. 16 Fig 3B shows a typical time course of the Lp changes in a single experiment.
Fig. 3C shows result summary (2 panels on the left).
Nitric oxide donor prevents AP-CAV induced leukocyte adhesion
To examine whether the AP-CAV-induced reduction of basal NO is responsible for
increased leukocyte adhesion, we applied a NO donor, SNP, during AP-CAV perfusion in
four vessels. The mean baseline Lp was 1.7 ± 0.1 ×10-7 cm·s-1·cmH2O-1. Each vessel was
first perfused with AP-CAV (10 μM) and SNP (10 μM) for 30 min, followed by 10 min of
resumed blood flow with superfusate containing SNP (20 μM). When each vessel was
recannulated with albumin-Ringer perfusate, the mean number of adherent leukocytes was
only 3.7 ± 1.1 per 100 μm of vessel length, which was a significant reduction from AP-CAV
perfusion alone and not significantly different from that of the baseline. The right panel of
Fig. 3A demonstrates the representative images before and after AP-CAV and SNP
perfusion followed by resumed blood flow from one single vessel. We also measured Lp
when vessels were perfused with SNP and AP-CAV, which showed no significant
difference from that of the control (Fig. 3C, 3rd panel from left).
Scrambled AP-CAV peptide does not affect leukocyte adhesion and microvessel Lp
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AP-CAV-X (10 µM) was used to examine the specificity of AP-CAV in another three
microvessels. Experiments were conducted under identical conditions to that of AP-CAV
application. No significant leukocyte adhesion or changes in Lp were observed after
resuming blood flow in AP-CAV-X perfused vessels. The mean number of adherent
leukocytes before and after resuming blood flow was 0.8 ± 0.1 and 1.1 ± 0.2 / 100 μm of
vessel length, and the mean Lp measured under each condition was 1.7 ± 0.2 and 1.8 ±
0.2 ×-7 cm·s-1·cmH2O-1, respectively (Fig. 3C, far right panel).
Inhibition of NOS by L-NMMA shows similar results to the application of AP-CAV
If AP-CAV-induced leukocyte adhesion is attributed to its inhibitory effect on basal NO,
we would expect the similar effect from the application of NG-Methyl-L-arginine (L-NMMA),
a NOS inhibitor. Experiments were conducted in three microvessels. Fig. 4A shows a
representative time course of the Lp changes in a single experiment. The mean control Lp
of three vessels was 2.4 ± 0.3×10-7 cm·s-1·cmH2O-1. After application of L-NMMA to both
perfusate (100 µM) and superfusate (500 µM) for 30 minutes followed by 20 minutes
resumed blood flow, the mean adherent leukocytes to the microvessel wall increased from
a mean baseline level of 0.8 ± 0.2 to 14.8 ± 2.5 per 100 µm of vessel length. Consistent
with the results of AP-CAV-induced leukocyte adhesion, Lp measured in the presence of
L-NMMA-induced adherent leukocytes was 2.7 ± 0.6 ×10-7 cm·s-1·cmH2O-1, not significantly
different from its control. When fMLP was applied to the perfusate, Lp measured after 5
min of stationary flow transiently increased to a mean peak value of 5.4 ± 0.9 times that of
the control. Fig. 4B summarizes the results.
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AP-CAV-induced leukocyte adhesion does not change endothelial adherens
junction
Our results showed that AP-CAV-induced leukocyte adhesion did not change basal Lp.
We then further examined the location of adherent leukocytes and whether the adherent
leukocytes cause local structural changes of endothelial junctions. Immunofluorescence
staining was used to simultaneously label adherent leukocytes and VE-cadherin in three
vessels. The representative confocal images shown in Fig. 5 illustrate that AP-CAVinduced leukocyte adhesion did not change the distributions of VE-cadherin at endothelial
junctions. Endothelial junctions were outlined by continuous VE-cadherin that had no
apparent interruptions, even underneath the site of the attached leukocyte. In addition, the
dual staining of both leukocyte and VE-cadherin demonstrated that the majority of adherent
leukocytes selectively adhered at or near endothelial junctions.
Reduced basal NO by AP-CAV increases the adhesive capacity of ICAM-1 on the
surface of endothelium lining microvessel walls.
Our results showed that leukocytes were firmly attached to the venular walls after
resuming blood flow in vessels that has been exposed to AP-CAV. We then investigated
whether AP-CAV-induced NO reduction affects the adhesive capacity of intercellular
adhesion molecule-1 (ICAM-1), an important molecule mediating the firm adhesion of
leukocytes to the vascular endothelium. A monoclonal blocking antibody directed against
ICAM-1 (mAb1A29) 17, 18 was used to evaluate the changes in adhesive activity of ICAM-1
on endothelial cells lining the venular walls after 30 min perfusion of AP-CAV. AP-CAV
perfusion at 1 and 10 µM significantly increased the mean FI of mAb1A29 to 2.4 ± 0.2 and
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9.5 ± 1.7 times that of the control, respectively (n = 4 per group). The application of 10 µM
SNP abolished AP-CAV-induced increases in mAb1A29 binding (n = 3), and perfusion of
AP-CAV-X (10 µM) showed no difference in mAb1A29 binding from that of the control (n =
3). Fig. 6 shows representative confocal images and summarized FI quantification of
mAb1A29 staining in 5 group of studies.
Anti-ICAM-1 blocking antibody attenuates AP-CAV-induced leukocyte adhesion
To confirm that the specific binding of mAb1A29 to ICAM-1 are directly associated with
the adhesive activity of ICAM-1, we perfused microvessels with mAb1A29 before and
during AP-CAV application. The initial number of adherent leukocytes under albuminRinger perfusion was 1.0 ± 0.3 per 100 μm of vessel length (n = 5). Each vessel was then
perfused with mAb1A29 (0.1 mg/ml) for 30 minutes followed by perfusion of AP-CAV (10
μM) in the presence of mAb1A29 for another 30 min before resuming blood flow. When
each vessel was re-cannulated with albumin-Ringer perfusate after 10 min of blood flow,
the mean number of adherent leukocytes was only 4.5 ± 0.8 per 100 μm of vessel length,
which is a significant reduction from that of AP-CAV perfusion alone (26.3 ± 3.2 per 100
μm of vessel length). Fig. 6C summarizes the results.
ICAM-1 Phosphorylation at Tyrosine 526 is required for AP-CAV-induced leukocyte
adhesion
Studies have demonstrated that TNF-α-induced early phase of leukocyte adhesion
involves Src activation-mediated phosphorylation of ICAM-1.

19, 20

We then examined

whether this mechanism also applies to AP-CAV-induced ICAM-1-dependent leukocyte
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adhesion using fluorescence immunostaining and confocal imaging. We found that 30 min
perfusion of AP-CAV (10 μM) caused a marked increase in ICAM-1 phosphorylation at
tyrosine 526 (Y526) on endothelial cells lining the venular walls compared to that of the
control. The same period of AP-CAV-X perfusion showed no such effect. Preferfusing
vessels with PP1 (10 µM), a src kinase inhibitor, abolished AP-CAV-induced ICAM-1
phosphorylation.

Representative confocal images are shown in Fig 7A and the FI

quantifications are summarized in Fig 7B (n = 3 per group). The role of AP-CAV-induced
ICAM-1 phosphorylation in AP-CAV-induced leukocyte adhesion was examined in another
3 vessels. Each vessel was first perfused with PP1 (10 μM) for 30 min before adding APCAV (10 μM) for another 30 min perfusion. After 10 min of resumed blood flow, the mean
number of adherent leukocytes was only 4.6 ± 0.1 per 100 μm of vessel length, which was
significantly lower than that of AP-CAV perfusion alone (26.3 ± 3.2 per 100 μm of vessel
length). Fig. 7C summarizes the results.
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DISCUSSION
Our study demonstrated for the first time that exogenously applied AP-CAV, in addition
to inhibition of stimulus-induced increases in NO production and microvessel permeability,
9, 10, 21

also reduces basal NO production in endothelial cells lining microvessel walls. Most

importantly, this study revealed how reduced basal NO affects the adhesiveness and
barrier function of endothelial cells in intact microvessels. While reduced basal NO by APCAV did not directly change basal microvessel permeability, it increased the adhesive
capacity of endothelial cells and promotes leukocyte adhesion via Src-mediated
phosphorylation of ICAM-1. Our results that NO donor abolished the effect of AP-CAV on
increased ICAM-1 binding to a blocking antibody and leukocyte adhesion support an
important anti-adhesive role of basal NO in maintaining the homeostasis of vascular walls.
Although the experiments focused on the effect of AP-CAV on microvessels, the identified
cellular mechanisms may represent the microvascular manifestations associated with
reduced basal NO under various pathological conditions in vivo.
CAV reduces basal NO production and promotes leukocyte adhesion in intact venules
The relationship between Caveolin-1 and eNOS is one of the fundamental discoveries
of caveolae involvement in cardiovascular functions. Cell culture and purified protein
binding studies demonstrated that caveolin-1 inhibits eNOS activity by a direct interaction
with eNOS through its N-terminal “scaffolding domain,” located between amino acids 82
and 101 within endothelial plasmalemmal caveolae.

7, 8, 22

Although the effect of the

caveolin-1 scaffolding domain peptide on eNOS activity has been extensively studied for
decades, most of the in vivo studies were conducted in vessels with acute exposure to
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inflammatory mediators. 9-11, 23 We previously demonstrated that when individually perfused
venules were exposed to PAF, the excessive NO production triggered by increased
endothelial [Ca2+]i was a necessary signal for permeability increases,

21, 24

and that the

application of AP-CAV, which inhibits PAF-induced NO, prevents the increases in
microvessel permeability. 9, 10 The systemic application of AP-CAV in mice has been shown
to suppress carrageenan and mustard oil-induced vascular leakage, as well as the
hyperpermeability of tumor vasculature. 11, 23, 25 These in vivo evidence suggest a promising
anti-inflammatory therapeutic potential of AP-CAV in protecting endothelial barrier function
through its inhibitory effect on inflammation-associated eNOS activation.

9-11, 26

However,

NO has also been known as an anti-adhesive molecule and plays anti-inflammatory roles
in preventing platelet and leukocyte adhesion on microvessel walls. 5, 27 How the inhibitory
action of AP-CAV on eNOS affects the anti-inflammatory roles of basal NO has not been
previously investigated. Detecting changes in basal NO requires a sensitive method,
because the magnitude of basal NO production is much smaller than that induced by
inflammatory mediators. Using continuous perfusion of NO indicator, DAF-2, to measure
basal NO is a new method recently developed in our laboratory.

14

This method enables

the endothelial cells lining the microvessel wall to maintain a relatively constant dye
concentration, which enhances the sensitivity of NO detection. Using this method, we
provided direct evidence that the exogenously applied AP-CAV, in addition to its role in
suppression of stimulus-induced increases in NO production and microvessel permeability,
also inhibits basal NO in intact venules and promotes leukocyte adhesion. The addition of
NO donor that reversed the CAV effect on leukocyte adhesion supports a causal
relationship between the reduced NO and increased leukocyte adhesion. Based on these
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findings we further investigated the mechanisms involved in increased adhesiveness of
microvessel walls by reduced basal NO and the impact of increased adhesive activity of
endothelium on microvessel permeability.
Role of basal NO in the regulation of microvessel permeability
NO has been recognized as an important endothelial factor that is not only a potent
vasodilator regulating vascular tone and blood pressure, but is also an important intrinsic
modulator of microvessel permeability.

4, 28-31

Despite decades of studies, the exact roles

of NO in the regulation of microvessel permeability remain controversial. Some studies
showed that the application of NOS inhibitors increased vascular leakages, especially in
the presence of blood.

4, 32-34

Others showed that inhibition of NO prevented permeability

increases in response to inflammatory mediators.

3, 9-11, 21, 23, 24, 26, 31, 35

The inconsistent

results were usually derived from different experimental approaches, organ vasculatures,
tissue conditions, and animal species. Our present study was conducted in intact
microvessels under basal conditions. Combined with our previous findings on stimuliinduced NO and microvessel permeability,

9, 10, 21, 24

we revealed dual actions of NO on

endothelial functions using the same experimental preparation, but under different
conditions, which provides a unified perspective of the roles of NO in the regulation of
endothelial function and microvessel permeability. Our results demonstrated that reducing
basal NO production by AP-CAV perfusion increased leukocyte adhesion through an
alteration of endothelial ICAM-1 adhesive capacity on the surface of endothelial cells lining
intact microvessel walls. Neither the increased adhesiveness of ICAM-1 alone, nor ICAM1-mediated leukocyte adhesion directly affect basal microvessel permeability. However,
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the presence of chemokines can trigger a respiratory burst from adherent leukocytes,
resulting in ROS-mediated increases in microvessel permeability (Fig 3 and 4). These
results demonstrate that the reduced basal NO does not directly increase permeability, but
rather primes the microvascular endothelial cells into an adhesive state. These findings
reveal the dual roles of NO in the regulation of endothelial functions in microvessels. While
basal NO plays anti-adhesive roles in maintaining the homeostasis of vascular walls, the
inflammatory mediator-induced excessive NO mediates increases in microvessel
permeability.
The relationship between reduced basal NO, ICAM-1 expression, leukocyte adhesion, and
microvessel permeability.
Leukocyte adhesion to microvessel walls has been characterized as a series of
coordinated interactions mediated by different adhesion molecules. During acute
inflammation, the rapid recruitment of leukocytes (minutes) usually involves P-selectin
translocation and the secretion of chemokines,

36, 37

which mediate loose interaction

between leukocyte and endothelium, such as rolling and tethering. Firm adhesion, usually
occurring hours after cytokine-mediated activation, is mediated by the enhanced
expressions of VCAM-1 or ICAM-1 that requires transcription and translation of new
proteins.

28

In contrast to this classical pattern of leukocyte/endothelium interactions, we

observed a large number of tightly adhered leukocytes in CAV- and L-NMMA-perfused
vessels within 10 and 20 min of resumed blood flow, respectively. The adherent leukocytes
were tightly attached to the microvessel walls and could not be washed away by reperfusing the vessel with albumin-Ringer perfusate, indicating ICAM-1-mediated adhesion.

50

Our results showed a 9.5 fold increase in ICAM-1 immunostaining in intact microvessels
following a 30 min CAV perfusion (images in Fig 6). In this study, the anti-ICAM-1 antibody
staining was achieved by direct perfusion of intact vessels with the antibody without fixation.
Therefore, the observed antibody binding with ICAM-1 should only represent the levels of
extracellular domain of ICAM-1 on the surface of endothelial cells. The timing of increased
ICAM-1 staining could rule out the possibility of new ICAM-1 synthesis. Studies have
demonstrated that mAb1A29 is a specific blocking antibody for ICAM-1 that inhibits ICAM1-mediated leukocyte adhesion.

17, 18

Our results that perfusing vessels with 1A29

significantly inhibited AP-CAV-induced leukocyte adhesion are consistent with those
reports. Then the increased binding affinity of ICAM-1 for this antibody upon AP-CAV
perfusion could be the results of increased adhesive binding sites of ICAM-1 for leukocyte
adhesion. While the evidence derived from our present study could not rule out the
possibility of membrane translocation of ICAM-1 in response to AP-CAV-induced NO
reduction, protein analysis from cytoplasmic and membrane fractions in cultured cells
reported that TNF-α-induced early phase leukocyte adhesion involves the activation of
constitutive ICAM-1 in cell surface. 19 We also explored the signaling pathways involved in
AP-CAV-induced increases in the adhesive activity of ICAM-1. The significant increases in
phospho-(Y526)-ICAM-1 staining following AP-CAV perfusion, not AP-CAP-X perfusion,
showed a direct correlation between ICAM-1 phosporylation and increased endothelial
surface ICAM-1 binding to mAb1A29. The application of a Src kinase inhibitor, PP1, that
abolished AP-CAV-induced ICAM-1 phosphorylation and also inhibited AP-CAV-induced
leukocyte adhesion supports that Src activation-mediated ICAM-1 phosphorylation resulted
in increases in the adhesive activity of ICAM-1. Src activation mediated ICAM-1
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phosphorylation that was independent of protein synthesis has also reported in TNF-αinduced early phase leukocyte adhesion in both cell culture and mouse lung studies

19, 20.

Our results that NOS inhibitor (L-NMMA) showed similar results to those of AP-CAVmediated leukocyte adhesion and that adding exogenous NO donor (SNP), or blocking
ICAM-1, prevented AP-CAV-induced leukocyte adhesion, support that reduced basal NOmediated, Src activation-dependent increases in adhesive activity of ICAM-1 is the
mechanism for AP-CAV-induced leukocyte adhesion. Most importantly, AP-CAV-induced
increases in adhesive activity of ICAM-1 on endothelial cells appears sufficient to mediate
firm adhesion of leukocytes within 10-20 min without the need of activating blood cells.
Consistent with our findings, overexpression of caveolin-1 was shown to reduced NO
production in vitro,
adhesion.

41

38-40

and eNOS-deficient mice show increased levels of leukocyte

A rapid increase (in 30 min) in ICAM-1 expression in thrombin-stimulated

umbilical vein endothelial cell was not inhibited by a protein biosynthesis inhibitor,
cycloheximide. 42 However, the mechanisms involved in the anti-inflammatory roles of NO
have been attributed to its ability to neutralize superoxide.

28, 43

It has been proposed that

eNOS-derived NO does not directly modulate endothelial cell conversion to a pro-adhesive
phenotype, but rather interferes with the generation of ROS by NADPH oxidase and
prevents ROS-mediated inflammatory response. 28, 44 In contrast to this proposal, the timing
and pattern of leukocyte adhesion observed in our studies strongly support a direct
association between basal NO and adhesive states of endothelial cells. Although detailed
molecular mechanisms remain to be discovered, our present studies indicate that the
signaling pathways involved in reduced basal NO-mediated leukocyte adhesion are
different from those induced by cytokines.
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Our results also demonstrated that CAV-induced leukocyte adhesion, without fMLP
stimulation, does not increase microvessel permeability. The continuous VE-cadherin
outlined underneath the AP-CAV-induced adherent leukocytes (Fig 5) provide further
evidence that the adhesion process did not cause local changes at endothelial adherent
junctions, which is consistent with the permeability measurements. These findings also
support that the process of leukocyte recruitments such as adhesion and migration may
not necessarily cause vascular leakage. Our results that the increases in microvessel
permeability only occurred upon the application of fMLP to vessels with AP-CAV-induced
adherent leukocytes, further support that the adhesion process alone can be dissociated
with increases in microvessel permeability, and the additional stimulus-induced leukocyte
oxidative burst is the direct cause of leukocyte adhesion-mediated increases in microvessel
permeability.

16, 45-50

This could also explain the effective anti-inflammatory actions of

systemically applied AP-CAV without reported injury of unaffected organs by several
investigators. 11, 23, 25, 29
Summary
Our experimental approach allows us to investigate microvessel functions under both
basal and stimulated conditions, and in the absence and presence of blood components,
thus providing us a unique opportunity to dissect the distinct roles of AP-CAV and NO in
the regulation of endothelial function in vivo under different vascular conditions. Our present
study on CAV-induced basal NO reduction, in combination with previous studies,
demonstrated that basal NO is essential in maintaining the non-adhesive state of
endothelium through regulating of endothelial surface adhesion molecules, whereas the
stimulated excessive NO causes increases in microvessel permeability. The reduced basal
53

NO-induced increases in adhesive activity of ICAM-1 to leukocytes were mediated by Src
activation-dependent ICAM-1 phosphorylation.
GRANT SUPPORT
This study was supported by National Heart, Lung, and Blood Institute grants HL56237 and
HL084338 (He, P.) and American Heart Association Great Rivers Affiliate 12PRE11470010
pre-doctoral fellowship (Xu, S.).

54

REFERENCE
1.

He P, Liu B, Curry FE. Effect of nitric oxide synthase inhibitors on endothelial [Ca2+]i
and microvessel permeability. Am J Physiol. 1997;272(1 Pt 2):H176-185.

2.

Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent
hyperpermeability in coronary venules. Am J Physiol. 1996;271(6 Pt 2):H2735-2739.

3.

Mayhan WG. Nitric oxide accounts for histamine-induced increases in
macromolecular extravasation. Am J Physiol. 1994;266(6 Pt 2):H2369-2373.

4.

Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J
Physiol. 1992;262(2 Pt 2):H611-615.

5.

Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of
leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88(11):4651-4655.

6.

Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human
platelet adhesion to vascular endothelium. Lancet. 1987;2(8567):1057-1058.

7.

Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric-oxide
synthase and caveolin-1 inhibits synthase activity. J Biol Chem.
1997;272(30):18522-18525.

8.

Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP,
Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and
caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol
Chem. 1997;272(41):25437-25440.

9.

Zhou X, He P. Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS
activity and microvessel permeability in rat venules. Cardiovasc Res.
2010;87(2):340-347.

10.

Zhu L, Schwegler-Berry D, Castranova V, He P. Internalization of caveolin-1
scaffolding domain facilitated by Antennapedia homeodomain attenuates PAFinduced increase in microvessel permeability. Am J Physiol Heart Circ Physiol.
2004;286(1):H195-201.

11.

Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In
vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and
reduces inflammation. Nat Med. 2000;6(12):1362-1367.

12.

Kendall S, Michel CC. The measurement of permeability in single rat venules using
the red cell microperfusion technique. Exp Physiol. 1995;80(3):359-372.

13.

Curry PE, Huxley VH, Sarelius IH. Techniques in microcirculation: measurement of
permeability, pressure and flow. In: Cardiovascular Physiology. Techniques in the
Life Sciences. New York: Elsevier; 1983.
55

14.

Zhou X, He P. Improved measurements of intracellular nitric oxide in intact
microvessels using 4,5-diaminofluorescein diacetate. Am J Physiol Heart Circ
Physiol. 2011.

15.

He P, Zhang X, Curry FE. Ca2+ entry through conductive pathway modulates
receptor-mediated increase in microvessel permeability. Am J Physiol. 1996;271(6
Pt 2):H2377-2387.

16.

Zhu L, He P. fMLP-stimulated release of reactive oxygen species from adherent
leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol.
2006;290(1):H365-372.

17.

Morisaki H, Suematsu M, Wakabayashi Y, Moro-oka S, Fukushima K, Ishimura Y,
Takeda J. Leukocyte-endothelium interaction in the rat mesenteric microcirculation
during halothane or sevoflurane anesthesia. Anesthesiology. 1997;87(3):591-598.

18.

Ferrante RJ, Hobson RW, 2nd, Miyasaka M, Granger DN, Duran WN. Inhibition of
white blood cell adhesion at reperfusion decreases tissue damage in postischemic
striated muscle. J Vasc Surg. 1996;24(2):187-193.

19.

Javaid K, Rahman A, Anwar KN, Frey RS, Minshall RD, Malik AB. Tumor necrosis
factor-alpha induces early-onset endothelial adhesivity by protein kinase Czetadependent activation of intercellular adhesion molecule-1. Circ Res.
2003;92(10):1089-1097.

20.

Liu G, Vogel SM, Gao X, Javaid K, Hu G, Danilov SM, Malik AB, Minshall RD. Src
phosphorylation of endothelial cell surface intercellular adhesion molecule-1
mediates neutrophil adhesion and contributes to the mechanism of lung
inflammation. Arterioscler Thromb Vasc Biol. 2011;31(6):1342-1350.

21.

Zhou X, He P. Temporal and spatial correlation of platelet-activating factor-induced
increases in endothelial [Ca(2)(+)]i, nitric oxide, and gap formation in intact venules.
Am J Physiol Heart Circ Physiol. 2011;301(5):H1788-1797.

22.

Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share
a common membrane-anchored scaffolding protein, caveolin. Caveolin binding
negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem.
1996;271(46):29182-29190.

23.

Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G.
Endothelial nitric oxide synthase activation is critical for vascular leakage during
acute inflammation in vivo. Proc Natl Acad Sci U S A. 2005;102(3):904-908.

24.

Zhu L, He P. Platelet-activating factor increases endothelial [Ca2+]i and NO
production in individually perfused intact microvessels. Am J Physiol Heart Circ
Physiol. 2005;288(6):H2869-2877.

56

25.

Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZL, Fairchild TA, Iwakiri Y, Groszmann
R, Claffey KP, Cheng YC, Sessa WC. Selective inhibition of tumor microvascular
permeability by cavtratin blocks tumor progression in mice. Cancer Cell.
2003;4(1):31-39.

26.

Bernatchez PN, Bauer PM, Yu J, Prendergast JS, He P, Sessa WC. Dissecting the
molecular control of endothelial NO synthase by caveolin-1 using cell-permeable
peptides. Proc Natl Acad Sci U S A. 2005;102(3):761-766.

27.

Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, Buja LM,
Willerson JT. Endogenous nitric oxide protects against platelet aggregation and
cyclic flow variations in stenosed and endothelium-injured arteries. Circulation.
1992;86(4):1302-1309.

28.

Kvietys PR, Granger DN. Role of reactive oxygen and nitrogen species in the
vascular responses to inflammation. Free Radic Biol Med. 2012;52(3):556-592.

29.

Cirino G, Fiorucci S, Sessa WC. Endothelial nitric oxide synthase: the Cinderella of
inflammation? Trends Pharmacol Sci. 2003;24(2):91-95.

30.

Kuhlencordt PJ, Rosel E, Gerszten RE, Morales-Ruiz M, Dombkowski D, Atkinson
WJ, Han F, Preffer F, Rosenzweig A, Sessa WC, Gimbrone MA, Jr., Ertl G, Huang
PL. Role of endothelial nitric oxide synthase in endothelial activation: insights from
eNOS knockout endothelial cells. Am J Physiol Cell Physiol. 2004;286(5):C11951202.

31.

Duran WN, Breslin JW, Sanchez FA. The NO cascade, eNOS location, and
microvascular permeability. Cardiovasc Res.87(2):254-261.

32.

Kurose I, Wolf R, Grisham MB, Granger DN. Effects of an endogenous inhibitor of
nitric oxide synthesis on postcapillary venules. Am J Physiol. 1995;268(6 Pt
2):H2224-2231.

33.

Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN.
Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ
Res. 1993;73(1):164-171.

34.

Rumbaut RE, Wang J, Huxley VH. Differential effects of L-NAME on rat venular
hydraulic conductivity. Am J Physiol Heart Circ Physiol. 2000;279(4):H2017-2023.

35.

Mayhan WG. Role of nitric oxide in modulating permeability of hamster cheek pouch
in response to adenosine 5'-diphosphate and bradykinin. Inflammation.
1992;16(4):295-305.

36.

Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat
Rev Immunol. 2007;7(10):803-815.

57

37.

Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation:
the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678-689.

38.

Fernandez-Hernando C, Yu J, Davalos A, Prendergast J, Sessa WC. Endothelialspecific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein
E-deficient mice. Am J Pathol. 2010;177(2):998-1003.

39.

Fernandez-Hernando C, Yu J, Suarez Y, Rahner C, Davalos A, Lasuncion MA,
Sessa WC. Genetic evidence supporting a critical role of endothelial caveolin-1
during the progression of atherosclerosis. Cell Metab. 2009;10(1):48-54.

40.

Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation
of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc
Biol. 2004;24(1):98-105.

41.

Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL,
Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient
mice. Am J Physiol. 1999;276(6 Pt 2):H1943-1950.

42.

Sugama Y, Tiruppathi C, offakidevi K, Andersen TT, Fenton JW, 2nd, Malik AB.
Thrombin-induced expression of endothelial P-selectin and intercellular adhesion
molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol.
1992;119(4):935-944.

43.

Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. Microvascular
responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res.
1995;76(1):30-39.

44.

Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide
synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res.
1994;74(6):1133-1140.

45.

Zeng M, Zhang H, Lowell C, He P. Tumor necrosis factor-alpha-induced leukocyte
adhesion and microvessel permeability. Am J Physiol Heart Circ Physiol.
2002;283(6):H2420-2430.

46.

Zhu L, Castranova V, He P. fMLP-stimulated neutrophils increase endothelial
[Ca2+]i and microvessel permeability in the absence of adhesion: role of reactive
oxygen species. Am J Physiol Heart Circ Physiol. 2005;288(3):H1331-1338.

47.

Tinsley JH, Ustinova EE, Xu W, Yuan SY. Src-dependent, neutrophil-mediated
vascular hyperpermeability and beta-catenin modification. Am J Physiol Cell
Physiol. 2002;283(6):C1745-1751.

48.

Jakus Z, Berton G, Ligeti E, Lowell CA, Mocsai A. Responses of neutrophils to antiintegrin antibodies depends on costimulation through low affinity Fc gamma Rs: full
activation requires both integrin and nonintegrin signals. J Immunol.
2004;173(3):2068-2077.
58

49.

Harris NR, Benoit JN, Granger DN. Capillary filtration during acute inflammation:
role of adherent neutrophils. Am J Physiol. 1993;265(5 Pt 2):H1623-1628.

50.

He P. Leucocyte/endothelium interactions and microvessel permeability: coupled or
uncoupled? Cardiovasc Res. 2010;87(2):281-290.

59

FIGURES AND FIGURE LEGENDS
Figure 1
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Figure 1. The application of Antennapedia homeodomain (AP)-caveolin-1 (CAV)
inhibits basal nitric oxide (NO). A: the time-dependent changes in cumulative DAF-2
fluorescence intensity (FIDAF) from one representative experiment before (○) and after (●)
treatment with 10 μM AP-CAV, followed by 10 μM SNP (△) perfusion for 40 min. B: timedependent changes in cumulative FIDAF from two representative experiments in the
absence (●) or presence of (○) of 500 μM l-NMMA. C: summary of NO production rate
derived from cumulative FIDAF in each group of vessels. The dashed arrow indicates the
time when DAF-2 fluorescence reached steady state. The arrow indicates the time when
testing solution was added. †Significant decreases from control (P < 0.05).
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Figure 2

Figure 2. Perfusion of AP-CAV for 30 min has no effect on basal hydraulic
conductivity (Lp). A: a representative experiment shows the time course of Lp changes
when the vessel was perfused with AP-CAV (10 μM). B: summary results of four
experiments.
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Figure 3
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Figure 3. Reduction of basal NO by AP-CAV induced significant leukocyte adhesion
without increasing Lp in the absence of a secondary stimulation. A: paired video
images from two rat venules. The two images on the left show the same vessel under
control conditions and after AP-CAV (10 μM)-induced leukocyte adhesion. The two images
on the right show that the application of sodium nitroprusside (SNP) abolished AP-CAVinduced leukocyte adhesion. B: the time course of Lp changes from a representative
experiment showing that AP-CAV (10 μM)-induced leukocyte adhesion (25/100 μm of
vessel length) did not increase Lp, unless formyl-Met-Leu-Phe-OH (fMLP) (10 μM) was
added to the perfusate. C: summary graph showing the correlation between the number of
adherent leukocytes (per 100 μm vessel length) and the changes in Lp in four group of
studies. Perfusion vessels with AP-CAV at 1 μM (n = 3) and 10 μM (n = 5) show AP-CAV
dose-dependent increases in leukocyte adhesion and fMLP-induced increases in Lp. The
application of SNP attenuated AP-CAV-induced leukocyte adhesion (n = 4), and replacing
AP-CAV with scrambled AP-CAV (AP-CAV-X) showed no effect on leukocyte adhesion (n
= 3). The blank bars represent the control values. The arrows indicate the procedures of
30 min of AP-CAV or AP-CAV-X perfusion followed by 10 min of resumed blood flow. The
dashed line bars represent values measured after resumed blood flow in AP-CAV or APCAV-X perfused vessels. *Significant increases from the control values (P < 0.05).
†Significant decreases from AP-CAV group (P < 0.05).
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Figure 4

Figure 4. L-NMMA, a NO synthase (NOS) inhibitor, showed similar effects on
leukocyte adhesion and microvessel permeability to those of CAV. A: time course of
Lp changes from a representative experiment. B: summary of the number of adherent
leukocytes (per 100-μm vessel length) and the corresponding changes in microvessel Lp
(n = 3). *Significant increases from control (P < 0.05).
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Figure 5

Figure 5. Confocal images of the co-staining of VE-cadherin and adherent leukocytes
illustrating that CAV-induced leukocyte adhesion did not change VE-cadherin
distribution. A: VE-cadherin staining under control conditions and after CAV-induced
leukocyte adhesion. The third image shows the double staining of VE-cadherin and
adherent leukocytes (indicated by arrows). B: magnified images from three different vessels
showing no changes in VE-cadherin at the adhesion sites.
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Figure 6. AP-CAV-induced increase in ICAM-1 adhesive capacity causes leukocyte
adhesion. A: representative confocal images of anti-ICAM-1 blocking antibody mAb1A29
and vascular cell nuclei co-staining from five groups of studies and the secondary antibody
control (ICAM-1 is shown in green, and nuclei are red). B: quantification of total
fluorescence intensity (FI) of ICAM-1 per unit area of vessel wall under control conditions
(n = 4), after AP-CAV (1 μM, n = 3; and 10 μM, n = 4) perfusion in the absence and presence
of SNP (n = 3), and after AP-CAV-X perfusion (n = 3). C: perfusion of vessels with mAb1A29
significantly attenuated AP-CAV (10 μM)-induced leukocyte adhesion (n = 5 per group).
*Significant increase from control (P < 0.05). †Significant decrease from AP-CAV group (P
< 0.05).
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Figure 7. AP-CAV-induced leukocyte adhesion involves Src activation-mediated
ICAM-1 phosphorylation at tyrosine 526 (Y526). A: representative confocal images
demonstrate increases in ICAM-1 phosphorylation at Y526 following AP-CAV perfusion
relative to that of the control. Such increased ICAM-1 phosphorylation was blocked by the
application of a Src kinase inhibitor, PP1, and was absent in vessels perfused with APCAV-X or secondary antibody alone. Phosphorylated ICAM-1 at Y526 is shown in green,
and nuclei are red. B: summary of changes in FI of phospho-Y526-ICAM-1 relative to
control in each experimental group (n = 3 per group). C: perfusion of vessels with PP1 that
prevented ICAM-1 phosphorylation also significantly attenuated AP-CAV induced
leukocyte adhesion (n = 3). *Significant increase from control (P < 0.05). †Significant
decrease from AP-CAV group (P < 0.05).
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ABSTRACT
Rationale Acute changes of shear stress (SS) have been recognized to play important
roles in vascular dysfunctions. However, detailed mechanisms involved in SS-induced
endothelial cell (EC) signaling and vascular barrier function in vivo have not been well
understood, especially in the presence of red blood cells (RBCs).
Objective This study investigates the effects of acute changes of SS on EC [Ca2+]i, eNOS
activation, nitric oxide (NO) production, and vascular barrier function in individually perfused
intact rat mesenteric venules.
Methods and Results SS was quantified by measuring maximal flow velocity and fluid
viscosity using a high-speed camera and a cone-plate viscometer. EC [Ca2+]i and NO were
measured in Fura-2 AM and DAF-2 DA loaded venules. EC eNOS activation was evaluated
by immunofluorescence staining with confocal imaging. ATP released from RBCs was
measured by bioluminescence assay. In response to changes of SS, transient SSdependent increases in EC [Ca2+]i occurred only in vessels perfused with whole blood or
perfusate containing RBCs, which were correlated with EC gap formation illustrated by
fluorescent microsphere accumulation. Whereas, both plasma and whole blood perfusion
induced

SS-dependent

NO

production

and

eNOS-Ser1177

phosphorylation.

Carbenoxolone, a Pannexin 1 inhibitor, abolished SS-dependent ATP release from RBCs
and also prevented SS-induced increases in EC [Ca2+]i and EC gap formation.
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Conclusions These results indicate that SS-induced ATP release from RBCs causes an
increase in EC [Ca2+]i and vascular permeability, and that SS-induced NO production can
be independent of increased EC [Ca2+]i in intact venules.
Keywords: shear stress; microvessel; permeability
Non-standard Abbreviations and Acronyms
SS = shear stress
EC = endothelial cell
NO = nitric oxide
eNOS = endothelial nitric oxide synthase
RBC = red blood cell
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INTRODUCTION
In the circulatory system, sustained fluid shear stress (SS) has been implicated to play
important roles in maintaining vascular wall endothelium integrity, and changes of SS or
disrupted flow patterns contribute to the pathogenesis of many disease-associated vascular
dysfunction.1 Although the effects of SS on endothelial cell (EC) functions have been
extensively investigated in both cell culture and in intact microvessels, the results are still
controversial and the detailed mechanisms remain not well understood. Most of the SSrelated studies were conducted in cultured endothelial monolayers, which have provided
important means to elucidate the relationship between SS and endothelial function.2-7
However, it has also been recognized that the cultured ECs grown under static conditions
usually have 10-100 times higher baseline permeability compared to intact microvessels,
and have been considered as pro-inflammatory phenotype,8 therefore, their responses to
mechanical forces may not fully replicate in vivo conditions. Additionally, under in vivo
conditions, the fluid in the vascular system is not a cell-free fluid. It contains blood cells that
also subject to SS under different flow conditions. Studies on red blood cells (RBCs) have
indicated that SS plays important roles in triggering RBC to release bioactive agents, such
as ATP, that regulate many important vascular functions.9-13 However, previous studies of
the effects of SS on vascular endothelium, either in cultured endothelial monolayers2-7 or
in individually perfused microvessels,14-16 were mainly conducted in the absence of blood
cell components, whereas the studies of the effects of SS on blood cells, such as RBCs,
usually do not involve vascular endothelium.9-13
Considering current contradictory results relating to the effects of SS on ECs, such as
the SS-induced changes of EC [Ca2+]i, the Ca2+ dependence of SS-induced NO production,
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and the effect of changing of SS on vascular permeability, our study aims to provide a better
understanding of these issues by focusing on direct comparisons of the effects of SS
generated by cell-free fluid (i.e. plasma and dextran solutions) and whole blood on EC
[Ca2+]i, NO production, and EC barrier integrity using individually perfused intact venules in
rat mesentery. ECs respond differently to constant versus transient changes of SS.1 Our
studies were focused on the effects of transient increases in SS. The changes of SS were
generated by changing flow velocity and perfusion pipet diameter and mimic some of the
geometric or pathological changes that occur in the vasculature in vivo. We first quantified
the wall SS by measuring the maximal RBC velocity and fluid viscosity using a high-speed
camera and a cone-plate viscometer. EC [Ca2+]i and nitric oxide (NO) were measured in
Fura-2 AM and DAF-2 DA loaded venules when the SS was generated by different
perfusates. EC eNOS activation was evaluated by immunofluorescence staining with
confocal imaging. SS-induced ATP released from RBCs is measured by bioluminescence
assay. Changes of microvessel permeability upon changing SS was evaluated by the
endothelial gap formations using fluorescence microspheres. The involvement of pannexin
1 channel on RBCs in SS-induced ATP release and its relationship with endothelial Ca2+
and microvessel permeability were also investigated.
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METHODS
Animal preparation
Experiments were carried out on venular microvessels in rat mesenteries. Female SpragueDawley rats (2–3-mo old; 220–250 g body wt; Hilltop Lab Animals, Inc.; Scottdale, PA) were
used for all of the experiments. Sodium pentobarbital was used for anesthesia and given
subcutaneously at an initial dosage of 65 mg/kg body weight with an additional 3-mg dose
given as needed. The trachea was intubated, and a midline surgical incision (1.5–2 cm) was
made in the abdominal wall. A loop of the ileum was gently extended from the abdominal
cavity and the mesentery spread over a glass cover slip attached to an animal tray. The
upper surface of the mesentery was continuously superfused with mammalian Ringer’s
solution, maintained at 37°C. All experiments were carried out on venular microvessels with
diameters ranging between 40 to 45 μm. Each experiment was performed on a single
microvessel with one experiment per animal. The investigation conforms to the Guide for the
Care and Use of Laboratory Animals (NRC Eighth edition 2010). All procedures were
approved by the West Virginia University Animal Care and Use Committee.
Quantification of shear stress in individually perfused venules.
Wall SS, the tangential force exerted per unit area of fluid-endothelium surface, is determined
by shear rate and viscosity. Wall Shear rate (γ), determined by mean fluid velocity (Vmean)
and vessel diameter (D), is calculated by the equation γ = 8Vmean / D.17 A Photron-FASTCAM
high-speed camera was used to record images at 500 frames/sec for flow velocity
measurements. ImageJ analysis software with the MTrackJ plugin was used to quantify the
center line red blood cell velocity (Vmax), the maximum red blood cell velocity in laminar flow
76

parabolic profile. The mean fluid velocity (Vmean) is calculated as Vmax / 1.6.17 Perfusate
viscosity was measured using a Wells-Brookfield cone/plate digital viscometer (LVTDCP). In
the designed experiments, a single venular microvessel was cannulated with a glass
micropipette and perfused with albumin-Ringer solution (control) or other perfusate solutions.
Hydrostatic pressure, controlled by a water manometer, was applied through the micropipette
to the microvessel lumen to control the ﬂow rate. Wall shear stress was modulated by
changing shear rate through changing perfusion pressure or the composition of the
perfusate.
Measurements of endothelial [Ca2+]i
Endothelial [Ca2+]i was measured in individually perfused microvessels using the fluorescent
Ca2+ indicator fura 2-AM. Experiments were performed on a Nikon Diaphot 300 inverted
microscope equipped with a Nikon photometry system including photometer head and finder
(P101), computer-controlled shutter, and filter changer (Lambda 10-2; Sutter Instrument;
Novato, CA). A rectangular variable diaphragm located in the photometer finder determined
the size of the measuring window through which the fluorescence intensity (FI) was collected.
A segment of fura 2-AM-loaded vessel, at least 100 μm away from the cannulation pipet site
assuring laminar flow, was then positioned within the field of view of the measuring window.
The size of the window covered about 50 endothelial cells forming the vessel wall. A Nikon
Fluor lens (x20, numerical aperture, 0.75) was used to collect FI values. The excitation
wavelengths for fura 2-AM were selected by two narrow-band interference filters (340 ± 5
and 380 ± 5 nm; Oriel), and the emission was separated with a dichroic mirror (DM400) and
a wide-band interference filter (500 ± 35 nm; Oriel). The exposure time is 0.25 s. The ratios
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of the two FI values were converted to Ca2+ concentrations using an in vitro calibration curve.
A detailed description has been previously reported.18
Measurements of endothelial nitric oxide
Endothelial NO production was measured in DAF-2 DA loaded vessels using fluorescence
imaging. Experiments were performed on a Nikon Diaphot 300 microscope equipped with
a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled shutter
(Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as the light
source. The excitation wavelength for DAF-2 was selected by an interference filter (480/40
nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier
(535/50 nM). All the images were acquired and analyzed using Metafluor software
(Universal Imaging, West Chester, PA). To minimize the photo-bleaching, a neutral density
filter (0.5 ND) was positioned in front of the interference filter and the exposure time was
minimized to 0.12 sec at 1 min intervals. During the experiments, each vessel was first
perfused with albumin-Ringer solution containing DAF-2 DA (5 µM). Image collection was
started after 40 minutes of DAF-2 DA perfusion. All images were collected from a group of
endothelial cells located in the same focal plane of the vessel wall using a Nikon Fluor lens
(x20, numerical aperture, 0.75). Quantitative analysis was conducted at the individual
endothelial cell level using manually selected regions of interest (ROIs) along the vessel
wall. Each ROI covers the area of one individual cell as indicated by the fluorescence
outline. The tissue autofluorescence was subtracted from all of the measured FIs. Shear
stress-induced changes in fluorescence intensity (FI) were expressed as (FI/FI0) X 100,
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where FI0 is control FI level. The NO production rate was calculated as dFI/dt. Details have
been described previously.19
RBC preparation and ATP measurement
Blood was draw from the carotid artery with heparin (20 unit/ml) and was used immediately.
The blood was diluted to approximately 1% Hct in mammalian Ringer’s solution. The blood
suspension was then centrifuged at 500 × g for 5 min and the buffy coat removed. This
procedure was repeated another two times to obtain washed RBCs. Blood samples were
kept at room temperature throughout experiments. Packed RBCs were resuspended in 1%
albumin-Ringer’s solution. Immediately following exposure to shear stress in the
viscometer, RBC samples were removed and were mixed 50/50 with the luciferin/luciferase
assay mix (Sigma). The ATP level in each sample was measured for 20 sec using a
luminometer (AutoLumatPlus LB953, Berthold). The relative light unit (I) is proportional to
the concentration of extracellular ATP. A zero-shear control was taken for each prepared
solution (I0). The relative ATP release is reported as (I-I0)/I0.
Immunofluorescence staining and confocal imaging
The mesentery bearing each perfused vessel was fixed with paraformaldehyde, followed
by permeabilization with 0.1% Triton X-100 before exposure to the anti-phosphorylated
eNOS at Ser1177 (Abcam) or Thr495 (Cell Signaling Technology) antibody. The tissue was
then incubated with Alexa 488-conjugated secondary antibody (Invitrogen) at room
temperature for 2 h. Confocal images were obtained using a Leica objective x63 (HCX PL
APO, NA 1.2) with × 1.5 electronic zoom, and the vertical step was 0.3 μm. The mean FI of
individual endothelial cells was quantified by selecting three one square micron ROIs that
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within each cell and averaging the Z-axis stack of each ROI, using Leica confocal software.
The mean of the FI averaged from three stacks of ROIs estimated the individual endothelial
cell mean FI. The mean FI for each vessel segment was estimated by averaging the mean
endothelial cell FIs for three endothelial cells, and represented site specific eNOS
phosphorylation.
Visualization of endothelial gap formation in intact microvessels
We used fluorescent microspheres (FMs) as the marker to identify endothelial gap
formation. Briefly, each individual microvessel was perfused with a perfusate containing red
FMs (100 nm, 3.6 ×1011/ml) for 10 min with and without changes in SS. Confocal images
were collected following 10 min albumin-Ringer perfusion to remove the free FMs from the
vessel lumen. A stack of confocal images was obtained from each vessel at successive XY focal planes with vertical depth of 0.5 µm using Leica ×25 (NA 0.95) objective. The
accumulation of FMs at junctions between ECs was analyzed in images from lower half of
the complete Z-axis image stack of the vessel. The total FI of FM (area x depth x mean
intensity/pixel) for each vessel segment was quantified as total intensity/surface area of the
vessel wall under control or shear conditions. Details have been described previously.20
Measurements of fluid velocity in the perfusion pipette
To quantify the SS exerted on RBCs when they pass through the narrow perfusion pipette,
the fluid velocity in the perfusion pipette was measured with Photron-FASTCAM high-speed
camera at 250~1000 frames/sec. ImageJ analysis software with MTrackJ plugin was used
to quantify the center line red blood cell velocity (Vmax), the maximum red blood cell
velocity in laminar flow parabolic profile. The mean fluid velocity (Vmean) is calculated as
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Vmean = Vmax / 2(1- 8 / R2),21 and shear rate is calculated as 8Vmean / 2R, where R is
the radius of the certain cross section of a pipette. The power trendline in Excel (Microsoft
office) was used for regression analysis.
Solutions and reagents
Mammalian Ringer’s solution was used for the experiments. The composition of the
mammalian Ringer’s solution was (mM) 132 NaCl, 4.6 KCl, 2 CaCl2, 1.2 MgSO4, 5.5
glucose, 5.0 NaHCO3, 20 N-2 hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)
and Na-HEPES pH 7.4. Albumin-Ringer’s solution (BSA, 10 mg/ml) was used as control
solution. Fura-2 AM was purchased from Life Technologies, Grand Island, NY. DAF-2 DA
was purchased from Sigma, St. Louis, MO. All the fluorescent dyes were prepared in
DMSO for stock solution and at least 1:1000 dilution was made for the final working
solutions. All of the perfusates containing the test reagents were freshly prepared before
each cannulation.
Data analysis and statistics
All values are means ± SE. Paired t-test was used for paired data analysis. ANOVA was
used to compare data between groups. A probability value of P < 0.05 was considered
statistically significant.
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RESULTS
Quantification and modulation of wall shear stress in individually perfused
mesenteric rat venules
Wall SS is the product of shear rate and viscosity of the moving fluid. To quantify the SS in
individually perfused venules, we measured the viscosity of each perfusate using
cone/plate viscometer and calculated the shear rate by measuring velocity of each
perfusate under different perfusion pressure using high-speed camera. Fig 1A shows one
of the images captured at 500 frames per second in a blood perfused vessel. Viscosity of
each perfusate was measured at shear rate of 225 s-1 at 37°C. The mean viscosity of whole
blood from 9 rats with mean hematocrit at 45.0 ± 0.74% was 4.7 ± 0.12 cP. The viscosity
of rat plasma was 1.2 ± 0.04 cP (n = 5), and 10% Dextran 70 in 1% BSA solution was 4.6
± 0.13 cP (n = 3). Since each venule selected for the experiment has relatively constant

(perfusion pressure minus balance pressure) and shear rate with each perfusate (n = 3 per
group, Fig 1B). By multiplying the measured viscosity, Fig 1D demonstrates the relationship
between the net perfusion pressure and wall shear stress with each perfusate.
Only blood flow generated changes of shear stress induce transient increases in EC
[Ca2+]i in individually perfused venules
Studies in cultured ECs and arterioles indicated that intracellular Ca2+ plays an important
role in wall SS-mediated responses in vascular function.6,

22

In this study we first

investigated the changes in venular endothelial [Ca2+]i in response to the changes of wall
SS generated by different perfusates. The mean endothelial [Ca2+]i was 57 ± 4 nM when
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the vessel was perfused with Ringer’s solution containing 10 mg/ml of BSA at 1.1 Pa steady
SS. Then the same vessel was recannulated with a micropipette containing whole blood.
When the SS was increased from 0 to 1.1 Pa or 3.2 Pa, EC [Ca2+]i transiently increased to
206 ± 14 nM and 315 ± 22 nM, respectively (n = 5 per group). Fig 2A shows the changes
in EC [Ca2+]i from a representative experiment. However, the identical magnitude changes
in SS utilizing albumin-Ringer’s solution, plasma, or 10% Dextran70 perfusate did not
cause significant changes in endothelial [Ca2+]i (Fig 2B-D).
Both blood and plasma perfused venules show the magnitude of shear-dependent
EC NO production
Among currently reported SS-induced vasoactive factors, NO released from ECs is
considered as the most important factor in the regulation of vascular function. In venular
microvessels, as demonstrated in previous studies from our group23 and others,24 basal
NO plays anti-inflammatory roles by preventing leukocyte adhesion and platelet
aggregation, whereas inflammatory stimuli-induced NO plays a pro-inflammatory role and
increases microvessel permeability.25 In this study, we further investigated the NO
responses to the changes in SS in both blood and plasma perfused vessels. Using the NOindicator, DAF-2, and fluorescence imaging, we found that changes of SS induced
magnitude-dependent increases in NO production in both plasma and whole blood
perfused vessels. When the SS increased from 0 to 1.1 Pa and 0 to 3.2 Pa, the NO
production rate was 0.19 ± 0.02 AU/min and 0.48 ± 0.10 AU/min in plasma perfused vessels
(n = 3), and 0.13 ± 0.02 AU/min and 0.24 ± 0.02 AU/min in blood perfused vessels (n = 3,
Figure 3A and 3B). The higher NO-dependent DAF-2 signal detected in plasma-perfused
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vessels as compared to blood perfused vessels may be attributed to the scavenging of NO
by RBCs.
Shear stress-induced eNOS activation
To correlate SS-induced NO production with eNOS activation status, we examined eNOS
phosphorylation at Serine 1177 and Threonine 495 under the same experimental
conditions as those in which NO was measured using immunofluorescence staining and
confocal imaging (n = 3 per group). eNOS-Ser1177 phosphorylation showed similar
responses to blood and plasma perfusion-generated SS, and the levels of changes were
shear magnitude-dependent (Fig 4A-B). However, shear magnitude-dependent eNOSThr495 dephosphorylation only occurred in blood perfused vessels, and no significant
changes were found in plasma perfused vessels (Fig 4C-D).
ATP released from RBCs is responsible for shear stress-induced transient increases
in EC [Ca2+]i in individually perfused venules
One of the major differences between whole blood and plasma perfused vessels is the
presence of blood cells. Since the majority of the blood cells are RBCs, we examined
whether the presence of RBCs contributes to SS-induced changes in EC [Ca2+]i. Results
showed that perfusion of vessels with 1% albumin-Ringer perfusate containing 40%
(volume) of RBCs resulted a similar pattern of shear-induced increases in EC [Ca2+]i to
those in whole blood perfused vessels. EC [Ca2+]i transiently increased from 76 ± 6 nm to
218 ± 10 nM and 314 ± 30 nM when SS increased from 0 Pa to 1.1 Pa and 3.2 Pa,
respectively (n = 3, Fig 5A and B).
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Several studies have indicated that RBCs release ATP in response to shear, and that a
pannexin 1 channel on their membrane serves as a mechanical sensor and is responsible
for the ATP release.9, 26 We examined shear-induced ATP release from RBCs using a coneplate viscometer to generate SS and luciferin/luciferase assay to measure ATP. We found
that SS induced magnitude-dependent ATP release from RBCs, and preincubation of
RBCs with pannexin 1 inhibitor, carbenoxolone (100 µM), blocked the ATP release (n = 3,
Fig. 5C). Furthermore, perfusing microvessels with carbenoxolone (100 µM) treated RBCs
also abolished SS-induced increases in EC [Ca2+]i (Fig 5D). The mean EC [Ca2+]i were 71
± 21 nM and 80 ± 23 nM when SS was increased from 0 to 1.1 Pa and 3.2 Pa, respectively
(Fig 5B).
Shear stress-induced endothelial gap formation
Our previous study demonstrated that the magnitude of the accumulation of fluorescent
microspheres (FMs) at junctions between ECs is closely correlated with the degree of
endothelial gap formation and increased microvessel permeability.20 To determine whether
the change of SS results in increased microvessel permeability, FMs (100 nm) were added
to the blood or plasma perfusate to mark the endothelial gap formation upon changing SS.
We found that only in blood perfused vessels, increase of SS from 0 to 3.2 Pa induced
significant accumulation of perfused FMs at endothelial junctions and the FI of accumulated
FMs was 5.1 ± 0.5 times the 0 Pa control (Fig 6A right panel). The identical experimental
procedures performed in plasma perfused vessels showed no such effect (Fig 6A left panel,
n = 3). RBC solutions (40% hematocrit) also showed similar effects to blood perfused
vessels, with the FI of accumulated FMs being 6.9 ± 1.1 times the 0 Pa control (Fig 6B left,
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n = 5). When the vessels were perfused with 40% carbenoxolone-treated RBCs, the FI of
accumulated FMs was significantly decreased to 1.5 ± 0.1 times the 0 Pa control value (Fig
6B right, n = 6).
Additional shear stress exerted on RBCs when they pass through the perfusion
pipette
The identification of the roles of RBCs in shear-induced EC signaling and permeability
changes led us a further evaluation of the shear forces the RBCs experienced in individually
perfused microvessels. It has been reported that constricted RBCs from a wide channel to
a narrow channel in microfluidic devices generated sudden increase of SS on the RBCs,
which triggers the ATP release from the RBCs.9, 10 Based on those observations, our single
vessel perfusion technique essentially replicates the shear conditions of the microfluidic
devices with even larger magnitude changes in SS when the RBCs pass through the
narrow perfusion pipette during whole blood or RBC perfusion. Therefore, under our
experimental conditions, RBCs in the perfusate not only experienced the wall shear in the
vessel lumen, but also experienced a greater transient changes in shear when passing
through the tip of the perfusion pipette. We hypothesized that shear-induced ATP release
from RBCs contribute to the shear-dependent increases in endothelial [Ca2+]i. To quantify
the shear that RBCs experienced when they pass through the perfusion pipette, we
measured the RBC velocity near the pipette tip as the inner diameter narrowed (Fig 7A).
Fig 7 B-C shows the mean velocity profile of the RBCs within the perfusion pipette as a
function of the distance from the pipette tip, a factor linearly associated with the changes in
pipette diameter. When the wall shear conditions were increased from 0 to 1.1 Pa and 3.2
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Pa, respectively, the sharpest change in RBC velocity started at around 150 µm from the
upstream of the pipette tip (n = 3 for each group) and the maximum shear rate was about
10 time higher than they experienced in the vessel lumen, which may greatly contribute to
ATP-induced increases in endothelial [Ca2+]i.
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DISCUSSION
Our studies by direct comparisons of intact microvascular responses to SS generated
by cell-free fluids, such as plasma or solutions containing Dextran 70, with SS generated
by blood flow demonstrated that under in vivo conditions, the changes of blood flow affect
endothelium not only by fluid-generated wall SS, but also by shear-induced releases of
ATP from RBCs. Each component contributes to different EC signaling and affects
important vascular functions. Our results indicated that an increase of fluid-generated wall
SS induces increased EC NO production, which does not involve an increase in endothelial
[Ca2+]i. However, under in vivo conditions, i.e. in blood perfused vessels, the increased
shear exerted on RBCs induces shear-magnitude dependent ATP release. This SSdependent ATP release from RBCs causes increases in EC [Ca2+]i and endothelial gap
formation, an indication of increases in microvessel permeability. By linking the effects of
wall SS on endothelium with the effects of shear-induced ATP release from RBCs on
endothelium, our study provided new insight about how changes of blood flow affect
vascular functions in vivo.
Mechanisms of shear stress-induced increases in EC [Ca2+]i: the role of shearinduced ATP release from RBCs
It has been controversial for decades whether exposure of EC to flow is accompanied
by elevated cytoplasmic [Ca2+]i.6,
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Our results provided the first evidence in intact

microvessels that the changes of SS in plasma or similar viscous dextran-albumin-Ringerperfused vessels do not cause increases in EC [Ca2+]i, and the SS-induced increases in
EC [Ca2+]i only occur in blood perfused microvessels and require the presence of RBCs.
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Our experiments that measured SS-induced ATP release from RBCs in vitro in combination
with quantifications of SS exerted on RBCs through single vessel perfusion also provided
mechanistic explanations for RBC involved SS-dependent increases in EC [Ca2+]i in intact
microvessels.
Previous studies using an in vitro microfluidic approach or microbore tubing reported
that RBCs release ATP upon exposure to increased SS or cell deformation, and the amount
of ATP released was directly proportional to the number of RBCs and the magnitude of the
changes in channel diameter or flow rate.10, 11, 13, 28, 29, The pannexin 1 channel has been
reported to act as a mechanical sensor on the membrane surface of RBCs and to mediate
ATP release, as inhibition of pannexin 1 attenuates SS-induced ATP release.9, 26 However,
these studies did not involve endothelial cells, and to date the effect of SS-induced ATP
release from RBCs on the endothelium has not been well explored, especially in intact
microvessels. Our experiments using cone-plate viscometry to generate SS on RBCs in
the presence and absence of a pannexin 1 inhibitor further confirmed the role of the
pannexin 1 channel in the shear-dependent ATP release from RBCs. We previously

in EC [Ca2+]i and microvessel Lp.30 In this study, we not only quantified the wall SS with
different perfusates when the endothelial cell [Ca2+]i and NO production were measured,
but also analyzed the additional SS exerted on RBCs via micropipet perfusion of individual
microvessels. In addition to changes in shear within the lumen of the perfused microvessel,
RBCs experienced marked increases in SS when they passed through the narrow tip of
the perfusion pipette (Fig 7), The shear effects of micropipette perfusion was similar to the
narrow constriction design used in microfluidic channel studies, in which shear-induced
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ATP release was detected from RBCs passing through the constrictions.9, 10 Based on
those studies and our in vitro measurements of SS-induced ATP release from RBCs, we
predict that under our experimental conditions the increased SS on RBCs caused by
moving through narrow perfusion pipette and increased fluid velocity to raise wall SS
induced significant amount of ATP release from RBCs, and this increased ATP release
contributes to the observed increases in EC [Ca2+]i in blood perfused vessels. Our
experiments using carbenoxolone, a selective inhibitor of pannexin 1, which abolished SSinduced ATP release in vitro and SS-dependent increases in EC [Ca2+]i in blood perfused
intact microvessels (Fig 5C), provide further evidence that SS-induced increases in EC
[Ca2+]i are directly associated with ATP released from RBCs.. Although some cultured cell
studies reported SS-induced ATP release from ECs resulting in increases in EC [Ca2+]i,31
based on our EC [Ca2+]i measurements in plasma and dextran 70-perfused vessels, any
SS-induced EC released ATP was insufficient to cause increases in EC [Ca2+]i in intact
microvessels.
Shear stress induced EC NO production and eNOS activation
Although it has been well recognized that the changes of SS induce NO production from
ECs, the signaling mechanisms remain unclear, especially because there is a lack of in
vivo evidence. Prior in vitro studies on the role of Ca2+ in SS-mediated NO production have
been controversial. Some studies reported that SS-induced NO was independent of
external Ca2+, but was mediated by increases in cytoplasmic Ca2+ via Ca2+ release from
intracellular stores.6,
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Others reported that flow-induced NO release was blocked by

removal of extracellular Ca2+ or the application of Ca2+ and calmodulin (CaM) antagonists.7,
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There are also studies reported that flow-induced NO occurred independently of changes

in intracellular [Ca2+]i.34 These inconsistencies could be the result of the differences in
cultured cell species, ATP concentrations in culture media, and the applied flow patterns.
A study conducted in rabbit lungs indicated that mechanical force-induced NO synthesis
requires ATP release from RBCs.12 Our measurements of both NO and endothelial [Ca2+]i
responses in blood and plasma perfused intact microvessels demonstrated that similar
increases in fluid generated wall SS, with and without RBCs, induce increases in NO
production. However, only increasing SS with perfusion solutions with substantial numbers
of RBCs increased endothelial [Ca2+]i. These observations indicate that SS-induced NO
can be independent of increases in endothelial [Ca2+]i. The increases in SS-induced EC
[Ca2+]i observed in blood-perfused microvessels are dependent on the magnitude of SS,
but they are attributed to EC responses to shear-induced releases of ATP from RBCs. Our
result that blocking ATP release from RBCs abolished SS-induced increases in endothelial
[Ca2+]i supports this conclusion.
To further evaluate the Ca2+-independence of SS-induced NO production,, we
assessed the activation status of eNOS following the same experimental procedures as
those EC [Ca2+]i and NO were measured using immunofluorescence staining and confocal
imaging. Two separate amino acid residues are reported to be particularly important in
regulating eNOS activity: a serine residue Ser1177 and a threonine residue Thr495.35 Cultured
EC and isolated protein studies indicated that eNOS-Ser1177 phosphorylation represents a
Ca2+-independent

regulatory

mechanism

for

activation

of

eNOS,36

but

the

dephosphorylation of Thr495-associated eNOS activation depends on increased EC
[Ca2+]i.37 Our results that SS-induced eNOS-Ser1177 phosphorylation occurred in both
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plasma

and

whole

blood

perfused

vessels,

while

SS-induced

eNOS-

Thr495 dephosphorylation only occurred in blood perfused microvessels, are consistent with
the molecular characterization of each of the eNOS activation sites. These results further
support the hypothesis that the changes in wall SS in the absence of RBCs activate eNOS
via a Ca2+-independent mechanism, indicating the wall SS-induced NO production can be
independent from increases in EC [Ca2+]i. In the presence of RBCs, the SS-induced
activation of eNOS involves both Ca2+ dependent and independent mechanisms with Ca2+
dependent eNOS activation being the result of ATP-induced increases in EC [Ca2+]i.
Shear stress and microvessel permeability
Although studies in individually perfused microvessels in both frog and rat mesenteries
have consistently demonstrated flow-dependent increases in permeability to small solutes,
such as K+ and sodium fluorescein,38, 39 the results of flow-induced changes in permeability
to macromolecules and fluid (Lp) remain conflicting.14-16, 40 Studies using isolated perfused
pig coronary venules reported perfusion rate-dependent increases in permeability to
albumin.40 In individually perfused frog mesenteric venules, one study showed that the
initial measured Lp value was correlated with the blood flow rate prior to the vessel
cannulation,15 but others using the similar techniques reported no changes in Lp upon
changes in flow velocity or wall SS.14, 16, 38 Based on the measurements of flow-induced
permeability to small solutes, the changes occurred rapidly.38,

39

It is a great technical

challenge to quantitatively measure SS-induced hydraulic permeability following the
traditional single vessel perfusion and occlusion technique.21 To date, all of studies using
single vessel perfusion techniques were conducted in the absence of RBCs (i.e. <1% RBCs
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which serve as velocity markers), and therefore assess only cell-free fluid generated wall
SS. To overcome the technical difficulties of assessing SS-induced permeability to fluid and
macromolecules, especially in the presence of RBCs, we directly evaluated EC junctional
changes in response to changed SS using FMs as marker to assess EC gap formation.20
Our previous studies demonstrated that when FMs (100 nm diameter) were perfused into
platelet activating factor (PAF) stimulated rat venules, the amount of accumulated FMs at
EC junctions serves as an index for the dimension of gap formation between ECs (validated
by electron micrograph), and is temporally correlated with the time course of PAF-induced
Lp changes.20 Using this method, our current results demonstrated that changes of SS
generated by cell-free fluid (plasma or dextran 70-BSA-solutions) showed no significant
increase in accumulation of FMs at vascular walls, indicating no additional EC gap
formation. However, changes of SS generated with perfusion solutions containing 40%
RBCs increased EC gap formation, reflected by increased FM accumulation at EC
junctions. Significantly, this increased junctional accumulation of FMs was abolished when
RBCs were pre-treated with a pannexin 1 inhibitor, suggesting endothelial gap formation is
directly linked with RBC released ATP and ATP-induced increases in EC [Ca2+]i. SSinduced NO production alone (in the absence of RBC released ATP) showed no effect on
EC [Ca2+]i or EC gap formation. Based on our previous studies, all agonist-induced
permeability increases are associated with increases in EC [Ca2+]i.8, 18 Our present results
suggest that the agonist-induced Ca2+-dependent permeability regulation also applies to
RBC associated shear force-induced changes in microvessel barrier function.
Summary
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The main contribution of this study is that we demonstrated the response of endothelial
cells to changes in SS in intact venules. Our results revealed that under in vivo conditions,
ECs not only respond to fluid generated wall SS, but also to ATP released by RBCs in
response to shear and that this ATP plays important roles in altering EC integrity and
vascular permeability. The studies presented in this paper provide the basic mechanisms
that may explain and predict the roles of changing SS in different vasculature under both
physiological and pathological conditions. Variations in vascular geometry involving
narrowed regions, such as blood entry from small capillary to venules or at vascular
converging points, may expose the RBCs to high SS, cause the release of ATP, and
increase EC [Ca2+]i and EC gap formation in downstream vessels. Under pathological
conditions, such as arterial stenosis due to local atherosclerotic plaque formation, or
mechanical injury-induced local vascular remodeling and cell proliferation, may cause
similar responses which would exacerbate local inflammation and vascular damage.
Although further validation under those conditions is needed, our observations indicate that
the effect of SS-induced ATP release from RBCs should not be underestimated or omitted
when SS-induced changes in EC function is studied.
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Figure 1. Shear stress measurement in intact mesenteric venules. A) High speed
camera image of the blood flow in a rat mesenteric venule. B) Relationship of shear rate to
perfusion pressure using different perfusate solutions. C) Summary of different perfusate
viscosity measured by cone-plate viscometer D) Relationship of shear stress to perfusion
pressure using different perfusate solutions.
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Figure 2. Blood flow generated-shear stress induced transient increase in EC [Ca2+]i
in individually perfused venules. A) The time course of blood flow generated-shear
stress induced EC [Ca2+]i changes from a representative experiment. B-D) The time
courses of 1% BSA, plasma and 10%Dextran70 generated-shear stress induced EC [Ca2+]i
changes from respectively representative experiments E) Summary data show that only
whole blood perfusion at different perfusion pressure induced shear-magnitude dependent
transient EC [Ca2+]i increase (n = 5 for the blood group, n = 3 for the other groups) *
indicates a significant increase from the 1%BSA control, ** indicates a significant increase
from 1.1 Pa group generated by blood perfusion
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Figure 3
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Figure 3. Shear stress-induced EC NO production in rat mesenteric venules A) Time
course of representative experiments showed that both the onset of plasma and whole
blood perfusion-generated sudden change of shear stress induced shear-magnitude
dependent increases of EC NO production. B) Summary data from three vessels from each
group showed the rate of NO production over different magnitude of shear stress. *
indicates a significant increase from the from the 1.1 Pa group generated by the same
perfusate, ‡ indicates a significant increase from blood perfusion group at same shear
stress magnitude.
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Figure 4
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Figure 4. EC eNOS phosphorylation (eNOS-Ser1177 and eNOS- Thr495) in response to
different magnitudes of shear stress generated by either blood or plasma perfusion
in the perfused venules. A) Confocal images of shear-dependent phosphorylation of
eNOS-Ser1177 in blood and plasma perfused vessels. C) Confocal images of sheardependent dephosphorylation of eNOS- Thr495 in blood perfused group but not in plasma
ones. B&D) Summary of the fluorescence changes under different experimental conditions
(n = 3 for each group).* indicates a significant increase from the 0 Pa control, ** indicates
a significant increase from the lower shear stress group generated by the same perfusate,
† indicates a significant decrease from the 0 Pa control. †† indicates a significant decrease
from the 1.1 Pa group generated by blood perfusion.
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Figure 5.
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Figure 5. ATP release from erythrocytes are required for shear stress-induced
transient increase in EC [Ca2+]i in individually perfused venules. A) Summary of ATP
measurement from red blood cells exposing to shear stress in the presence and absence
of carbenoxolone B-C) Representative experiments shows 40%RBC in albumin ringer
solution perfusion induced shear-magnitude dependent EC [Ca2+]i transient increase, while
carbenoxolone incubated RBC solution using the same experiment procedure greatly
diminished the EC [Ca2+]i increase D) Summary data show that carbenoxolone abolished
the RBC solution induced EC [Ca2+]i transient increase. (n = 3 for each group). * indicates
a significant increase from the 1%BSA control, ** indicates a significant increase from the
1.1 Pa group generated by the same perfusate. † indicates a significant decrease from the
RBC perfusion group at the same shear stress magnitude.
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Figure 6
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Figure 6. Blood flow and RBC solution perfusion generated-sudden change of shear
stress induced endothelial cell gap formation. A) Representative confocal images
shows blood but not plasma perfusion generated sudden change of shear stress from 0 to
3.2 Pa induced gap formations B) Representative confocal images shows 40% RBC
solution generated sudden change of shear stress induced gap formations. While preincubation of RBC solution with cabenoxolone abolished the gap formation. C)
Quantificantion of the fluorescence intensity (FI) of accumulated fluorescent microspheres
(FMs) accumulation at endothelial junction. (n = 3 for Plasma 0 Pa, Plasma 3.2 Pa and
Blood 0 Pa, n = 6 for Blood 3.2 Pa and 40%RBC + CBX, n = 5 for 40%RBC 3.2 Pa) *
indicates a significant increase from the 0 Pa control, † indicates significant decreases from
the RBC perfusion group.
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Figure 7.
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Figure 7. Fluid velocity measurement inside cannulation pipette. A) A representative
image shows the dimension of a cannulation pipette. The changes in the pipette inner
diameter are relatively linear within 800 µm distance from the cannulation pipette tip where
fluid velocity was measured. B-D) Flow velocity and shear rate along the cannulation
pipette when the vessel lumen wall shear stress was suddenly changed from 0 to 1.1 and
3.2 Pa, respectively.
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ABSTRACT
Glycocalyx (GCX), a layer of proteoglycans covering the endothelium, has been implicated
as a mechanical sensor in sensing the changes in shear stress (SS) in vitro. Though acute
hyperglycemia has been reported to impair GCX in human by indirect volume estimation,
the direct experimental evidence and how the impaired GCX affects SS-mediated
endothelial function in vivo remain to be demonstrated. The objective of this study is to
identify the changes in GCX in microvessels of streptozotocin-induced diabetic rats and
evaluate the associated changes in sensing SS and SS-induced nitric oxide (NO)
production in individually perfused venules of diabetic rats. GCX is visualized either by
electron microscope (EM) or by lectin fluorescence labeling. EC NO production was
quantified in DAF-2 DA loaded vessels using fluorescence imaging. Microvessels of
diabetic rats showed degraded GCX by both EM and confocal images, a similar observation
found in pronase (0.1 mg/ml, 3 min) treated microvessels. Unexpectedly, the EC NO
production in response to blood flow-generated changes in SS in diabetic vessels was
significantly higher than that in normal vessels. The NO production rate in normal vessels
were 0.13 ± 0.02 and 0.24 ± 0.02 AU/min at 11 and 32 dyn/cm2. In contrast, the NO
production rate of diabetic vessel in response to the same magnitude changes of SS were
0.25 ± 0.05 and 0.37 ± 0.03 AU/min, respectively. These findings were also supported by
an increased NO production observed in pronase treated normal venules. Our results
indicate that the impaired GCX in diabetic microvessels enhances EC response to
mechanical force and potentiates NO production.
Key Words: glycocalyx, diabetic, microvessel permeability, nitric oxide
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INTRODUCTION
Wall shear stress is the tangential force exerted per unit area of the blood-endothelium
surface. How the endothelium senses changes in shear stress in intact microvessels has
not been well explored. The glycocalyx has been implicated as a mechanical sensor for
changes in shear stress. Using an indirect volume estimation method, endotoxemia and
hyperglycemia have been reported to cause damage to the glycocalyx coating on the
endothelial cell surface in human. However, direct experimental evidence and how the
impaired glycocalyx (GCX) affects shear stress-mediated endothelial function in vivo
remain to be demonstrated. A study in frog microvessels showed increases in hydraulic
conductivity (Lp) to be associated with the partial digestion of the endothelial glycocalyx.
Our recent study found increased basal permeability and enhanced permeability responses
to inflammatory mediators in venules of diabetic rats. Whether the increased permeability
in diabetic rats is the result of an impaired glycocalyx remains unknown. Here we conducted
experiments to test the hypothesis that hyperglycemia-induced damages to the glycocalyx
contribute to the increases in microvessel permeability in diabetic rats. Among the currently
reported vasoactive factors induced by shear stress, NO released from ECs is considered
as the most important factor in the regulation of vascular function. In the arterioles, it
regulates vascular tone, peripheral resistance, and tissue perfusion. In venular
microvessels, as demonstrated in previous studies from our lab and others, basal NO plays
anti-inflammatory roles by preventing leukocyte adhesion and platelet aggregation,
whereas stimuli-induced excessive NO production plays a pro-inflammatory role and
increases microvessel permeability. Therefore, this study was focused on shear stressinduced NO production under normal and diabetic conditions.
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METHODS
Animal preparation
Experiments were carried out on venular microvessels in rat mesenteries. All procedures
and animal use were approved by the Animal Care and Use Committee at West Virginia
University. Female Sprague-Dawley rats (2–3-mo old; body wt 220–250 g; Hilltop
Laboratory Animals; Scottdale, PA) were anesthetized with pentobarbital sodium given
subcutaneously. The initial dosage was 65 mg/kg of body weight with an additional 3 mg
dose given as needed. The trachea was intubated, and a midline surgical incision (1.5–2
cm) was made in the abdominal wall. The mesentery was gently moved out of the
abdominal cavity and spread over a glass cover slip attached to an animal tray. The upper
surface of the mesentery was continuously superfused with mammalian Ringer solution.
The temperature of the superfusate was maintained at 37°C. All experiments were carried
out on venular microvessels with diameters ranging between 40 and 50 μm. Each
experiment was performed on a single microvessel with one experiment per animal.
Fluorescence imaging of endothelial nitric oxide production
Endothelial NO production was measured in DAF-2 DA loaded vessels using fluorescence
imaging. Experiments were performed on a Nikon Diaphod 300 microscope equipped with
a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled shutter
(Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as the light
source. The excitation wavelength for DAF-2 was selected by an interference filter (480/40
nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier
(535/50 nM). All the images were acquired and analyzed using Metafluor software
(Universal Imaging, West Chester, PA). To minimize the photo-bleaching, a neutral density
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filter (0.5 ND) was positioned in front of the interference filter and the exposure time was
minimized to 0.12 sec at 1 min intervals. During the experiments, each vessel was first
perfused with albumin-Ringer solution containing DAF-2 DA (5 µM). Image collection was
started after 40 minutes of DAF-2 DA perfusion. All images were collected from a group of
endothelial cells located in the same focal plane of the vessel wall using a Nikon Fluor lens
(x20, numerical aperture, 0.75). Quantitative analysis was conducted at the individual
endothelial cell level using manually selected regions of interest (ROIs) along the vessel
wall. Each ROI covers the area of one individual cell as indicated by the fluorescence
outline. The tissue autofluorescence was subtracted from all of the measured FIs. Shear
stress-induced changes in fluorescence intensity (FI) were expressed as (FI/FI0) X 100,
where FI0 is control FI level. The NO production rate was calculated as dFI/dt. Details have
been described previously.1
Electron microscopy
The changes of glycocalxy was examined with electron microscopy. Each vessel was
perfused with Alcian Blue 8GX (0.05%) to stain the glycocalyx, while the upper surface of
the mesentery was superfused with a fixative solution. After fixation, a small panel of the
mesentery that contained the perfused microvessel was dissected and placed in the same
fixative at 4°C overnight. The specimens were then rinsed in 0.1 M phosphate buffer and
permeabilized with 50% ethanol. The samples were postfixed and transferred into
propylene oxide, and embedded in epon. Photomicrographs were taken on a JEOL 1220
transmission electron microscope
Confocal imaging
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Glycocalyx distrubution was also visualized with confocal imaging using FITC-conjugatedlectin (FITC-BS-1) that can specifically bind to components of the endothelial glycocalyx.
Leica TCS SL confocal microscope equipped with microvessel perfusion rig was used to
collect images. Each stack of images was acquired by optical sectioning at successive XY focal planes with vertical depth of 0.5 µm using Leica X 25 objective (HC Plan APO, NA
0.95) and 1024 x 1024 scanning format. Leica software was used for image acquisition and
image analysis.
Visualization of Endothelial gaps formation in intact microvessels
We used fluorescent microspheres as the marker to identify endothelial gap formation.
Briefly, each individual microvessel was perfused with a perfusate containing red
fluorescent microspheres (FMs, 100 nm, 3.6 ×1011/ml) with and without the sudden change
of shear stress for 10 min. Confocal images were collected following 10 min albumin-Ringer
perfusion to remove the free FMs from the vessel lumen. A stack of confocal images was
obtained from each vessel at successive X-Y focal planes with vertical depth of 0.5 µm
using Leica ×25 (NA 0.95) objective. The accumulation of FMs at junctions between
endothelial cells was analyzed in images from lower half of the complete Z-axis image stack
of the vessel. The total FI of FM (area x depth x mean intensity/pixel) for each vessel
segment was quantified as total intensity/surface area of the vessel wall under control or
shear conditions. Details have been described previously.2
Solutions and reagents
Mammalian Ringer’s solution was used for the experiments. The composition of the
mammalian Ringer’s solution was (mM) 132 NaCl, 4.6 KCl, 2 CaCl2, 1.2 MgSO4, 5.5
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glucose, 5.0 NaHCO3, 20 N-2 hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)
and Na-HEPES pH 7.4. Albumin-Ringer’s solution (BSA, 10 mg/ml) was used as control
solution. Fura-2 AM was purchased from Life Technologies, Grand Island, NY. DAF-2 DA
was purchased from Sigma, St. Louis, MO. All the fluorescent dyes were prepared in
DMSO for stock solution and at least 1:1000 dilution was made for the final working
solutions. All of the perfusates containing the test reagents were freshly prepared before
each cannulation.
Data analysis and statistics
All values are mean ± SE. Paired t-test was used for paired data analysis. ANOVA was
used to compare data between groups. A probability value of P < 0.05 was considered
statistically significant.
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RESULTS
Impaired glycocalyx in diabetic rat venules
Cultured cell studies showed that glycocalyx degradation is correlated with decreases
in shear stress-induced NO production and with increases in permeability of EC
monolayers.3-5 Decreased glycocalyx volume has been reported in diabetic patients.6 A
study in frog microvessels showed increases in hydraulic conductivity (Lp) to correlate with
the partial digestion of the endothelial glycocalyx.7 However, whether the hyperpermeability
in diabetic rats is the result of impaired glycocalyx has not been studied in vivo. We
hypothesize that the hyperglycemia caused glycocalyx damage may contribute to the
increases in microvessel permeability in our STZ-induced diabetic rats. The electron
micrograph with Alcian Blue 8GX staining shown in Fig 1A directly shows that the
glycocalyx was impaired in microvessels of diabetic rats. In addition to the electron
microscopic studies, we developed another method to visualize the glycocalyx distribution
using confocal imaging with FITC-conjugated-lectin (FITC-BS-1) that can specifically bind
to components of the endothelial glycocalyx.8 Fig 1B lower left panel is a single scan of the
FITC-BS-1 labeled glycocalyx of a normal vessel (focal plane at the center of the vessel
lumen) and Fig 1B upper panel is the projection image from the lower half X-Y z-stack
images. Fig 1B also shows the disappearance of glycocalyx after 5 min of pronase
(0.1mg/ml) treatment.
Impaired glycocalyx enhances EC NO production to shear stress
The glycocalyx has been indicated as a mechanotransduction sensor to the fluid shear
stress in many in vitro studies.9-12 Using enzyme degradation of its specific components
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impaired the shear stress induced NO production and increased permeability in vitro.13 In
the proposed studies, we will investigate the role of the glycocalyx in the regulation of shear
stress-induced changes in microvessel functions in intact venules. Since NO is one of most
importance EC vascular factor induced by shear stress, we first investigate the change of
EC NO to shear stress in diabetic rats with impaired glycocalyx. Our results in Fig 2 showed
enhanced NO production when normal blood was perfused into diabetic venules. The NO
responses to different magnitudes of shear stress were even higher than those measured
in pronase treated normal venules. These results suggested that both a damaged
glycocalyx and altered ECs may contribute to this enhanced EC NO production to shear
stress.
Increased microvessel permeability to shear stress in diabetic rats
Excessive NO production induced by inflammatory mediators contributes to an increase
in microvessel permeability and plays a pro-inflammatory role.

14-16

Thus, our next step is

to investigate whether the microvessel permeability changes to shear stress in enhanced
in diabetic rats. Our previous study found that the changes in the magnitude of FM
accumulation closely correlated with the time course of PAF-induced increases in hydraulic
conductivity (L(p)), indicating that the accumulation of FM reflects the degree of EC gaps
formation and related microvessel permeability.2 In Fig 3, venules of diabetic rats perfused
with 1% BSA (control) at 1.1 Pa shows moderate gap formation. Blood perfusion-generated
shear stress at 3.2 Pa significantly potentiated the EC gaps formation (compare the right
panels between A and B), indicating increased sensitivity of diabetic vessels in response
to mechanical force.
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DISCUSSION
Wall shear stress is the tangential force exerted per unit area of the blood-endothelium
surface. The glycocalyx, a layer of proteoglycans covering the endothelium, has been
indicated to be a mechanotransduction sensor for changes of shear stress.12 Impaired
glycocalyx has been suggested may directly contribute to the increased leukocyte
adhesion, hyperpermeability, and other microvascular dysfunctions associated with
diabetes and other cardiovascular diseases. In our present study, we found the impaired
glycocalyx increases the endothelial susceptibility to shear stress, which resulting in
augmented nitric oxide production in microvessels of diabetic rats.
The experiments were conducted in individually perfused microvessels with undisturbed
surrounding circulation, which we consider extremely important. In order to translate the
remarkable knowledge gained from in vitro studies into clinical therapeutic applications, it
is essential to evaluate cellular and molecular mechanisms in their native state.
Multidimensional protein identification revealed that 41% of proteins expressed in vivo are
not detected in vitro, indicating that distinct in vivo protein expression is apparently
regulated by the tissue microenvironment and cannot yet be duplicated in standard cell
culture.17 This is specifically important for glycocalyx studies, because the glycocalyx under
static cultured cell growth is not as well developed as that under physiological conditions.
The endothelial cell glycocalyx has been reported to have 0.2 to 0.5 µm thickness lining
the luminal surface of all blood vessels.18 A human study indicated that glycocalyx volume
is reduced in hyperglycemia patients.6 However, they estimated systemic glycocalyx
volume by comparing the distribution of glycocalyx permeable tracer (dextran 40) with
glycocalyx impermeable tracer (using labeled erythrocytes). This methodology raises some
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concerns for its validity.19 No direct evidence had previously been demonstrated for an
impaired glycocalyx in diabetes. Here, we directly visualize the loss of glycocalyx in diabetic
animal using electron microscopy and immunofluorescence confocal imaging.
The glycocalyx has been indicated as a mechanotransduction sensor to the fluid shear
stress in many in vitro studies.9-12 Using enzyme degradation of its specific components
impaired the shear stress induced NO production and increased permeability in vitro.13 Our
data suggested that removing the glycocalyx enhanced EC NO production, which indicated
that impaired glycocalyx enhances EC responses to mechanical force. Interestingly, we
also found the NO responses to different magnitudes of shear stress were even higher than
those measured in pronase treated normal venules. It suggested that besides the damaged
glycocalyx, the altered ECs in diabetic rats may also contribute to this enhanced EC NO
production to shear stress.
Nitric oxide (NO) is mainly produced from endothelial cells driving from shear stress in
the vasculature under physiological condition. It has been currently demonstrated to play
important roles in the regulation of microvessel barrier function. Basal level of endothelial
NO production protects vascular wall from leukocytes adhesion, platelets aggregation,
thrombosis, and atherosclerotic plaque formation.20 On the other hand, inflammatory
mediator-stimulated increased NO production in endothelial cells is essential for increasing
the microvessel permeability.21,

22

Our previous study on individually perfused intact

venules showed that platelet activating factor (PAF) induces transient increases in
microvessel permeability through both Ca2+ and NO dependent pathway.23 However, the
exactly role of NO in regulating microvessel permeability is still unknown.
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Our future study will further investigate the causal relationship among impaired
glycocalyx, enhanced shear stress induced NO production, and enhanced vascular
permeability, as well as the involved cellular mechanisms.
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FIGURES AND FIGURE LEGENDS
Figure 1.

A

Normal

200 nm

Diabetic

B

After pronase
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Diabetic

Single scan

projection

Control

Figure 1 Direct visualization of glycocalyx in rat venules using EM and confocal
imaging A: The electron micrograph with Alcian Blue 8GX staining of GCX shows impaired
GCX in a rat mesenteric venule. B: Confocal images illustrating glycocalyx by FITCconjugated-lectin (FITC-BS-1) staining in intact mesenteric venules. Upper panel is the
projection image from the lower half X-Y z-stack images. Lower panel is a single scan of
the FITC-BS-1 labeled glycocalyx of a normal vessel (focal plane at the center of the vessel
lumen). Fluorescence intensity is significantly decreased in diabetic and pronase
(0.1mg/ml, 5 min) treated venules, indicating the loss of glycocalyx layer at endothelial
surface.
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Figure 2
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Figure 2. Endothelial NO production in response to blood flow-generated shear
stress is significantly enhanced in both diabetic and pronase treated rat mesenteric
venules. Shear stress was changed from 0 to 1.1 Pa or 3.2 Pa, in each experiment,
respectively. The graph shows that the NO production rates in diabetic and pronase treated
vessels were significantly higher than that in a normal vessel in response to the same range
of changes in shear stress, indicating the impaired glycocalyx increased endothelial
sensitivity to mechanical force (N=3 in each group).
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Figure 3
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Figure 3. Shear stress-induced EC gap formation is enhanced in venules of diabetic
rats. Accumulation of fluorescent microspheres (FMs, red) is used to mark endothelial
gaps. Images were collected after the start of changing shear stress with different
perfusate. Each image is the projection of the lower half of the z-stack images. A) Venules
of normal rats perfused with 1% BSA (control) at 1.1 Pa shows no FM accumulation and
perfusion of blood at 3.2 Pa induces small magnitude of EC gaps; B) Venules of diabetic
rats perfused with 1% BSA (control) at 1.1 Pa shows moderate gap formation, which may
represent the moderate basal Lp increase found in diabetic rats and can be independent
from the shear stress (left panel). A sudden change of blood perfusion-generated shear
stress to 3.2 Pa significantly potentiated the EC gaps formation (compare the right panels
between A and B), indicating increased sensitivity of diabetic vessels in response to
mechanical force.

127

CHAPTER 5
IN VITRO RECAPITULATION OF FUNCTIONAL MICROVESSELS FOR THE STUDY
OF ENDOTHELIAL SHEAR RESPONSE, NITRIC OXIDE AND [Ca2+]I
Xiang Li 1ǂ, Sulei Xu2ǂ, Pingnian He2, Yuxin Liu 1,*
1 Lane

Department of Computer Science and Electrical Engineering
West Virginia University, Morgantown, WV 26506
2

Department of Physiology and Pharmacology

West Virginia University, Morgantown, WV 26506
* Corresponding Author: Tel: 3042939144; Fax: 3042938602; e-mail:
yuxin.liu@mail.wvu.edu
ǂ Equal contribution authors

128

ABSTRACT
A physiologically realistic microvessel model for studying complex vascular phenomena,
such as endothelial cell signaling and barrier functions, is much needed to biologists
because of critical constraints of current microvessel models having the resolution at
individual cell levels, in vitro models are lack of stable and mature endothelium with
appropriate barrier functions, while in vivo animal studies are often too complex and have
high experimental costs. Microfluidic technologies have enabled in vitro studies to closely
simulate the in vivo microvessel environment with sufficient complexity. However, there are
still gaps of knowledge and a generalized lack of validation of these models as adequate
model of a functional microvessel. In this paper, we presented an engineered microfluidic
microvessel model, demonstrated in vitro formation of microvessels that recapitulate key
features of the microvessels in vivo, and validated its utility for biological applications. Our
microvessel model illustrates unique capabilities in advanced micromanufacturing and
microfluidic technologies to create a model mimicking the dimensions of in vivo
microvessels with long-term, continuous perfusion control, as well as real-time high-quality
imaging capability. Cells in our model maintain their phenotype, viability, proliferation with
proper barrier functions, and respond to flow shear force and inflammatory stimuli. In
particular, primary human umbilical vein endothelial cells were successfully cultured along
the entire inner surface of the microchannel network with morphologies close to those
reported in venular vasculature and well-developed VE-cadherin junctions throughout the
channels. The endothelial cell responses to shear stresses were quantified under different
flow shear conditions. Furthermore, we successfully measured agonist-induced changes in
intracellular Ca2+ concentration [Ca2+]i and nitric oxide (NO) production in individual
129

endothelial cell levels using our model. The results were similar and comparable to those
derived from individually perfused intact venules. With the in vivo validation of its
functionalities, our microfluidic model demonstrates a great potential for biological
applications and bridging the gaps between in vitro and in vivo microvascular research.
Key words: microfluidics, HUVECs, microvessel network, shear responses, ATP, [Ca2+]i,
nitric oxide
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INTRODUCTION
The development of microfluidic devices has been embraced by engineers over two
decades. However, the adaptation and application of microfluidics in mainstream biology is
still lacking. According to the recent summary, the majority publications of microfluidics are
still in engineering journals (85%).1 The equivalent or improved performance of microfluidic
devices is not convincing enough for many biologists to switch from current state-of-the-art
techniques such as Transwell assay and macroscale culture dish/glass slide.1, 2 The most
common way to replicate certain features of in vivo shear stress by biologist includes
parallel flow chamber and cone and plate viscometer.3 Microfluidics has the advantage to
provide a solution that has not been addressed by those macroscale approaches, such as
developing a more physiologically relevant in vitro model. In this paper we continue our
previous efforts in developing an in vitro functional microvessels that could provide a
platform for the study of complex vascular phenomena.4
A physiologically realistic microvessel model is able to overcome certain critical
constraints of the current in vitro models, such as creating a stable and mature endothelium
with appropriate barrier functions. Additionally, the advanced models, that enable a close
simulation of in vivo environment with sufficient complexity, could work as artificial
surrogates for curtailing high experimental costs and complexities associated with animals
and in vivo studies.5 Several groups have pioneered in the development of advanced
microvessel models, which applied micromanufacturing and microfluidic techniques, used
either polymer or hydrogel to template the growth of vascular endothelial cells (ECs), cocultured ECs with other vascular cells, demonstrated cell viability, and appropriate functions
in angiogenesis and thrombosis.6-9 Nonetheless, prior methodologies did not demonstrate
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and quantify some key features for microvessels, such as intracellular Ca2+ concentration
([Ca2+]i) and nitric oxide (NO) production in cultured microvessels with well-developed
endothelial junctions. NO, is essential for controlling vascular tone and resistance in
arterioles, and regulating vascular wall adhesiveness and permeability in venules.10
Additionally, the endothelial [Ca2+]i plays an important role in microvessel permeability,11,12
angiogenesis13 and morphogenesis.14 However, in microfluidic based systems, there are
very limited reports for measurements of [Ca2+]i and NO production.15, 16, 19, 20 Some studies
reported DAF-2DA loaded endothelial cells from a microfluidic network,17,18 and ATPinduced NO production was reported on cultured bovine pulmonary artery endothelial cells
within a straight microfluidic microchannel. However, there is a lack of reports of
quantification of time-dependent changes in NO production under basal and stimulated
conditions, and agonist-induced changes in [Ca2+]i in endothelialized microchannels.
In this paper, we presented an in vitro formation of a microvessel network that
recapitulates key features of microvessels in vivo. The microfabrication technique
accurately controls the dimensions of the developed microchannels in microscales which
mimicking those of in vivo microvessels. In addition, continuous microfluidic perfusion is
able to control the mass transfer and flow shear stresses precisely. A confluent endothelial
monolayer was formed and fully covered inside the entire microchannel network. To further
validate the functionalities of developed microvessels, the vascular endothelial adherens
junctions were confirmed by the VE-cadherin immunofluorescence staining. We also
evaluated the cell morphology changes in response to different patterns of shear stress.
Additionally, endothelial [Ca2+]i and NO production were quantitatively measured under
control and stimulated conditions.
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MATERIAL AND METHODS
Design and Fabrication
The microchannel network designed in this paper was a three-level branching
microchannels as shown in Fig. 1. The smallest width of the microchannel was 100 µm.
Standard

photolithography

was

used

for

the

master

mold

fabrication

and

polydimethylsiloxane (PDMS) soft lithography was used for the microfluidic microchannel
network fabrication (Fig. 1).21 Briefly, a silicon wafer was rinsed with acetone and methanol
and baked on a hot plate (150°C) over 30 minutes for dehydration (Fig. 1(a)). SU-8
photoresist (SU8-2050, Microchem) was spun-coated over the pre-cleaned silicon wafer
with a thickness of 100 µm, and then the wafer was baked on the hot plate at 65°C and
95°C, respectively (Fig. 1 (b)). The designed patterns were transferred from a film mask to
the SU-8 thin film after the UV light exposure (OAI model 150, Fig. 1 (c)), post baking, and
the development as shown in Fig. 1 (d). After the hard baking at 150°C, the developed
patterns as the master mold were ready for the PDMS soft lithography. The PDMS (Slygard
184, Dow Chemical) was mixed at a weight ratio of 10:1, and cast onto the master mold to
replicate the microchannel patterns (Fig. 1 e). PDMS was cured and peeled off from the
master mold after it was baked in an oven at 60°C for 3 hours. The inlet and the outlet,
which were used for the cell loading, tubing connections, media and reagent perfusion, and
waste collection, were punched with a puncher (1 mm, Miltex). In a typical confocal
microscopy system, the objective lens with high numerical apertures (NA) has a limited
working distance in a range of a few hundred microns.22 Therefore, to incorporate the
microfluidic devices to the confocal system, the number 1 glass coverslip (thickness of 130160 µm, Fisher Scientific) spun-coated with a thin layer of PDMS (thickness of 20 µm) was
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used as the substrate for the device bonding (Fig. 1 (f)). A permanent bonding was created
to seal the microchannels completely after oxygen plasma treatment (50 W, 100 mtorr) of
PDMS for 30 seconds.
Numerical Simulation of Shear Stress Distribution
To analyze shear stress distributions inside the microchannel networks, a fluid dynamic
analysis model using COMSOL multiphysics software (Version 4.0.0.982, COMSOL Inc.)
was built to numerically simulate shear flows.21 Incompressible Navier-Stokes equations
were chosen as governing equations for the fluids, and no-slip wall boundary condition was
set along the internal surface of the microchannels except for the inlet and the outlet.
Cell Culture
Primary human umbilical vein endothelial cells (HUVECs) were purchased from Lonza.
The cells were maintained in MCDB 131 culture medium (Gibco, Life Technologies)
supplemented with 10% fetal bovine serum, 1% L-glutamine, 0.1% Gentamicin, 0.05%
bovine brain extract (9mg/mL), 0.25% endothelial cell growth supplement (3mg/mL), and
0.1% heparin (25mg/mL) in tissue cultured flasks, which were pre-coated with 0.2% gelatin.
The cell culture was performed in a humidified atmosphere of 5% CO2 at 37°C, and the
cells between passage 2 and passage 5 were used for this study. When the cultured
HUVECs reached confluent, the cells were harvested and re-suspended in 8% Dextran
(mol wt 70,000, Sigma) diluted with MCDB 131 culture medium. Dextran was used to
increase the medium viscosity for better controlling cell seeding inside the microchannels.
Prior to cell loading, the device was treated with oxygen plasma for 3-5 minutes to reduce
the hydrophobicity of inner surfaces of PDMS microchannels. The device was then loaded
with deionized water and sterilized under the UV light exposure for 8 hours in a laminar
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biosafety hood. After UV sterilization, the device was rinsed with 1× phosphate buffered
saline (PBS), coated with fibronectin diluted in 1×PBS (100 µg/mL, Gibco, Life
Technologies), and incubated at 4°C inside a refrigerator for overnight. After this, the device
was rinsed with 1×PBS again to remove the fibronectin solution completely, and loaded
with cell media. Finally, the device was incubated for 15 minutes at 37°C and was ready
for cell loading.
To load the cells, a droplet (10 µL) of HUVECs was placed at the inlet, and a slow flow
was created by either tilting the device, or placing a glass pasteur pipette (the inner
diameter of the pipets is around 1.5 mm, VWR) at the outlet. Capillary action through the
microchannels was gently introduced by the glass pipette and the cells slowly moved along
the media into the channels. The key for a successful cell loading was to control the flow
velocity very slowly, otherwise, most of the cells cannot attach uniformly inside the
microchannels. After 15-20 minutes incubation in the incubator, the attached cells can be
visually confirmed under the microscope. An additional loading can be performed if
necessary. After a satisfied cell seeding density was reached, the device was gently rinsed
with the media to remove the dextran solution. A complete attachment requires five to six
hours. Long-term continuous perfusion was set up by a syringe pump system (Harvard
Apparatus) with a steady flow rate of 0.35 µL/min. The perfusion can last up to two weeks,
and can be adjusted to maintain different flow patterns if necessary.4
Confocal Fluorescence Imaging of Intracellular Calcium Concentration
Fluo-4 was selected for confocal Ca2+ imaging. Image acquisition was conducted on a
Leica TCS SL confocal microscope with a Leica ×25 objective (NA: 0.95). An argon laser
(488 nm) at 50% power was used for excitation, and the emission band was 510–530 nm.
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To minimize photobleaching, fluo-4 images were collected using a 512 × 512 scan format
at a z-step of 2 μm. Stacks of images were collected from the same group of HUVECs with
20 seconds intervals. Each network device was first loaded with fluo-4 AM (5 μM) for 40
minutes followed by albumin-Ringer perfusion to rinse the lumen fluo-4 AM before control
images were collected. Quantitative analysis of endothelial [Ca2+]i at the individual
endothelial cell level was conducted using manually selected ROIs along the
microchannels. Each ROI covered the area of one individual endothelial cell, as indicated
by the fluorescence outline. The changes in endothelial [Ca2+]i at the cellular levels were
quantified by calculating the mean FI of each stack of ROIs after the subtraction of the
background auto fluorescence. The percent change in FI was expressed as FI/FI0*100,
where FI0 was the initial baseline FI of fluo-4. Details have been described previously.25
Confocal Fluorescence Imaging of Nitric Oxide Production
Endothelial NO levels were investigated at the cellular levels in the microvessel network
using DAF-2 DA, a membrane-permeable fluorescent indicator for NO, and fluorescence
imaging. Experiments were performed on a Nikon Diaphod 300 microscope equipped with
a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled shutter
(Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as the light
source. The excitation wavelength for DAF-2 was selected by an interference filter (480/40
nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier
(535/50 nM). All the images were acquired and analysed using Metafluor software
(Universal Imaging).
Each network device was first perfused with albumin-Ringer solution containing DAF-2
DA (5 μM) for 35~40 minutes before collecting DAF-2 images. DAF-2 DA was present in
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the perfusate throughout the experimental duration. All images were collected from a group
of HUVECs located in the same focal plane using a Nikon Fluor lens (x20, NA: 0.75). Data
analysis was conducted at the individual endothelial cell level using manually selected
regions of interests (ROIs). Each ROI covered the area of one individual cell as indicated
by the fluorescence outline. The PDMS auto fluorescence was subtracted from all of the
measured fluorescence intensities (FIs). The basal NO production rate was calculated from
the slope of the mean FI increase during albumin-Ringer perfusion after DAF-2 loading was
reached the steady state. The changes in FIDAF upon ATP stimulation were expressed as
the net changes in FI (∆FI). FI was expressed in arbitrary units (AU) measured with identical
instrumental settings. The rate of FIDAF change was derived by first differential conversion
of cumulative FIDAF over time. Details have been described previously.23, 24
Immunofluorescent Staining
HUVECs were fixed in 2% paraformaldehyde solution (Electron Microscopy Science)
for 30 minutes by perfusing the fixing solution into the network. The cells were blocked with
1 mg/mL bovine serum albumin (BSA, Sigma) in PBS solution for 30 minutes followed by
permeabilization with 0.1% Triton X-100 (Sigma) for 5 minutes. The primary antibody (VEcadherin) was perfused at 4 °C for overnight. Then, the second antibody (Alexa488,
Invitrogen) was perfused for 1 hour at the room temperature. Finally, the cell nuclei were
stained with DRAQ 5 (Biostatus). The F-actin staining followed the similar fixing, blocking,
and permeabilizing procedures, and then stained with phalloidin-Alexa 633 (Sigma) for 10
minutes, followed by the DRAQ5 nuclei staining. Fluorescent images were obtained using
an inverted optical microscope (Nikon Ti-E inverted live-cell imaging microscope) and a
confocal laser-scanning microscope (Leica TCS SL), respectively.
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Cell Morphology Analysis in Response to Shear Stress
To study the actin cytoskeleton and HUVECs morphology changes under shear
stresses, different scenarios were performed to vary the culture and shear flow conditions.
Detailed experimental conditions are listed in Table 1. Briefly, after initial seeding three
different flow conditions were set for the same patterned networks in different devices as
shown in Table 1: Low shear culture, low shear test (LSC-LST); Low shear culture (till the
ECs reached confluence), high shear test (LSC-HST); and high shear culture, high shear
test (HSC-HST). The transition from low shear stress to high shear stress was gradually
applied by programming a step function (10 steps of increase in 18 hours) using the syringe
pump (Harvard Apparatus).
Quantitative analysis was performed to examine HUVEC morphology changes (i.e.
aspect ratio and cell surface area) in responses to different levels of shear stresses. The
aspect ratio was defined as the length of the primary axis (d1, along the flow direction)
divided by the length of the secondary axis (d2, perpendicular to the flow direction). A cell
was considered as an ellipse shape and the corresponding cell surface area was calculated
as

πd1 d2
4

.

Data analysis and statistics
For statistical analysis, data was presented as the mean ± standard error (SE) and each
individual experiment was performed at least three times (n≥3). Statistical significance of
detected difference between groups was tested using the single-factor ANOVA.

138

RESULTS
Characterization of the Endothelial Adherens Junctions in Microvessels Developed
in Microchannel Network
With the initial cell loading concentrations of 2 ~ 4 × 106 cells/mL, confluent monolayers
developed within 3-4 days under a constant flow of culture media. Fig. 2 shows the confocal
images of endothelial cell F-actin and cell nuclei staining at different regions of the network
in the same device, which illustrates that HUVECs successfully cultured the entire inner
surface of the network to confluence. We also examined the junctional formation between
ECs as an indication of endothelial barrier function. VE-cadherin, an important protein for
the maintenance and control of the junctions between endothelial cells, was immunestained in the entire microchannel. Fig. 3 shows the confocal images of VE-cadherin and
nuclei staining at different regions of the microchannel. The confocal images illustrate that
VE-cadherin was well developed throughout the entire network (Fig. 3 b-d), demonstrating
a continuous distribution between ECs with less lattice-like structure that often appeared in
statically cultured endothelial monolayers.26 The VE-cadherin distribution in the
microchannels is closer to that demonstrated in intact microvessels,12 suggesting that the
continuous flow condition during cell growth provide a better environment for appropriate
EC spreading, viability, proliferation, and formation of junctions.
Endothelial Cell Responses to Shear Stress
To quantify the shear stress, which the endothelium lining the microchannels
experienced under our experimental conditions, we conducted a numerical simulation. The
calculated wall shear stresses were 1.0 dyne/cm2 under the flow rate 0.35 µL/min, and 10
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dyne/cm2 under the flow rate 4.05 µL/min within the selected regions in the devices as
shown in Fig. 4a-b.
Flow related shear stress has been shown to induce changes in cell shape and
cytoskeletal structure of vascular ECs in vivo and in vitro.27, 28 In this study, we evaluated
the cytoskeletal rearrangement of F-actin fibers and cell shape changes in response to
three patterns of flow related shear stress within the microchannel networks: continuous
low shear without a change (LSC-LST); low shear culture with high shear exposure (LSCHST); and continuous high shear exposure (HSC-HST). The flow rate and correlated shear
stress under each condition are listed in Table 1. Under the LSC-LST conditions, about
70% of the cells show cobblestone pattern with dominated peripheral F-actin, and only 30%
of the HUVECs showed elongated cell shape with increased central stress fibers aligned
along the flow direction. Under LSC-HST and HSC-HST conditions, about 50% of the cells
were elongated with distinct stress fibers along the flow direction. In each scenario, the cell
shape aspect ratio in non-aligned cells was about 1.5 ± 0.03 and the aligned cells was 3.97
± 0.19, 3.93 ± 0.22 and 3.95 ± 0.19 in LSC-LST, LSC-HST, and HSC-HST, respectively.
Fig. 4c-g shows representative images from each group and the quantifications of their
changes in morphology, including aspect ratio and cell surface areas, in those aligned and
non-aligned cells, respectively. The aligned cells in high shear stress test groups (LSCHST and HSC-HST) demonstrated significantly reduced surface areas (1855 µm2 and 1234
µm2) compared to those cells under low shear stress conditions (LSC-LST, 2202 µm2, Fig.
4).
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Measurements of Endothelial Calcium Concentration ([Ca2+]i) in response to ATP
Increases in endothelial [Ca2+]i have been demonstrated to play important roles in the
regulation of a variety of microvessel functions including endothelial barrier function, i.e.
microvessel permeability. In individually perfused microvessels, inflammatory mediator
commonly induces transient increases in endothelial [Ca2+]i followed by transient increases
in microvessel permeability. To validate the biological functions of the microvessels
developed under flow in our model, we applied the method developed in individually
perfused intact microvessels25,

29

to the microvessels developed in the microchannel

network and quantitatively measured the changes in endothelial [Ca2+]i when the
microvessel was exposed to ATP. Experiments were conducted in four devices with fluo-4
loaded endothelial cells. When ATP (10 µM) was perfused to each device, [Ca2+]i in all
endothelial cells under the view reached a peak at 35 ± 10 seconds with the mean peak
[Ca2+]i at 187 ± 22% of the control. Representative fluo-4 images and the fluorescence
quantification are shown in Fig. 5.
Measurement of ATP-induced Nitric Oxide Production
In intact venules, it has been demonstrated that inflammatory mediator-induced
increases in endothelial [Ca2+]i was associated with increased NO production, and both
increased endothelial [Ca2+]i and NO production contribute to increases in microvessel
permeability.24,

25

With demonstrated ATP-induced increases in endothelial [Ca2+]i, we

further measured NO production in response to ATP in DAF-2 loaded endothelial cells
lining the microchannels.
When ATP (10 µM) was added, the rate change in ATP-induced NO production was
measured with continuous DAF-2 DA perfusion.23 Each device was first perfused with
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albumin-Ringer solution containing DAF-2 DA (5 μM) for 35~40 minutes before collecting
images. After the loading phase, the rate change of FIDAF under control conditions was 0.15
± 0.05 AU per min, which was close to the basal NO production rate measured in intact rat
mesenteric venules.10, 23, 30 When ATP (10 µM) was added to the perfusate, the rate change
in FIDAF was significantly increased. The peak rate of FIDAF increase was 1.18 ± 0.37 AU
per min. The increased FIDAF returned to the control level after 10~15 minutes of ATP
exposure. Data were derived from 3 devices with a total of 35 ROIs and 11 to 12 ROIs per
vessel. NO donor, sodium nitroprusside (SNP), was added at the end of each experiment
to verify the sufficiency of DAF-2 in the cells and the responsiveness of DAF-2 to NO. Fig.
6 shows the quantification of time-dependent changes in FIDAF and correlated images from
an individual experiment. The changes in slopes of the FIDAF indicate the changes in NO
production rates before and after ATP stimulation. Images in Fig. 6 (b) illustrate the ATPinduced cumulated increases in FIDAF at 10 minutes of ATP exposure.
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DISCUSSION
Our study presented the in vitro formation of a microvessel network using a microfluidic
device and characterized endothelial junctions, cellular responses to shear stresses, and
quantitatively measured the changes in endothelial [Ca2+]i and NO production before and
after exposure to ATP. The results demonstrated that this engineered microvessel network
recapitulates the key aspects and fundamental functions of in vivo venules, and reveals its
promising utility for biological applications including studies with human samples.
With advanced microfabrication techniques, the flexibility to create patterns and scale
sizes provides users with arbitrary design options to mimic the geometries of in vivo
microvasculature, which allows the functional studies involved in complex flow patterns
found at vessel bifurcations and in regions of high curvature that occur in vivo. This
microfluidic microvessel network with thin PDMS film layer bonded on a thin glass substrate
(average total thickness is 170 µm) allows excellent light transmission and easy adaptation
to both bright field and fluorescence microscopy when using short working distance and
large numerical aperture objectives. Our study demonstrated that this device is capable for
real-time and high-resolution imaging to detect changes in intracellular molecules and cell
morphology using fluorescent markers, which is a necessary feature for biological studies.
This modification is a further progress of applying our previous studies using
endothelialized microvessel network.4, 21
The main difference of using this microchannel network compared with traditional cell
culture is that the cells, instead of growing under static conditions at 2-dimensional flat
surface, were growing in a three dimensional channel with continuous flow, which made
the cell culture environment closer to the in vivo situation. The numerical simulation
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provides an accurate estimation of the wall shear stress distribution. Based on the channel
dimensions and simulation, the applied shear stress was easily controlled within the range
of venous system (1 to 10 dyne/cm2).31, 32 Our study characterized the biological functions
of these cultured microvessels under basal and stimulated conditions, and validated its
utility for biological applications. Our results indicated that the endothelial cells grown under
flow conditions form better monolayers with well-developed junctions between endothelial
cells as that demonstrated by VE-cadherin staining. As shown in Fig. 2, the HUVECs
completely covered the entire inner surfaces of the channels including the corners and
formed a completely enclosed network. Most importantly, the VE-cadherin staining showed
a uniformly distributed band between endothelial cells within the network, which is similar
to that observed in intact venules,12, 33 and distinct from the intricate lattice-like structure
commonly found in statically cultured endothelial monolayers.34
The major technical improvement for biological and physiological application reported
in this study is the quantitative measurements of agonist-induced changes in endothelial
[Ca2+]i and NO production at individual cell levels in a well-developed microvessel network.
Studies in individually perfused intact microvessels indicated that inflammatory mediatorinduced increases in endothelial [Ca2+]i is essential for increases in microvessel
permeability and that the magnitude of the [Ca2+]i determines the degree of permeability
increases.29, 45-48 In addition, agonist-induced Ca2+/calmodulin-dependent endothelial nitric
oxide synthase(eNOS) activation and NO production have been shown to play important
roles in the regulation of microvessel permeability.24, 25, 49 In this study, we directly applied
the methods developed in individually perfused intact microvessels23, 29 to this cultured
microvessel network and conducted parallel studies to those performed in the intact
144

microvessels in vivo. Currently the uses of microfluidics to study intracellular calcium50, 51
and NO responses52 have been reported by a few investigators. However, the calcium
studies were either from suspended leukemic cells50 or from non-confluent osteoblasts.51
Though ATP-induced NO has been reported in BPAEC cultured microfluidic device, there
was no characterization of the junctions of endothelial cells in which NO was measured and
no temporal resolution of NO production was analysed in that study.52 In our study, we
choose ATP as the representative agonist to study receptor-mediated changes in
endothelial [Ca2+]i and NO production. ATP can be released by red blood cells, aggregated
platelets, and injured tissue or under inflammatory conditions. The increased levels of ATP
cause the release of endothelial-derived relaxing factor and trigger the synthesis of
prostacyclin, and increase in microvessel permeability by increasing endothelial [Ca2+]i.48,
53, 54

The action of ATP is primarily via the purinergic P2y receptor expressed on most types

of endothelial cells.55,

56

The calcium measurements using fluo-4 as indicator in the

microvessel network showed similar responses to what we found in intact microvessels.25,
48

As for NO measurements using DAF-2 DA, we need to recognize the specific manner of

DAF-2 chemical conversion in the presence of NO and conduct data analysis
accordingly.23, 57 DAF-2 DA is membrane permeable and diffuses freely into the cells driven
by concentration gradient and is then hydrolyzed by cytosolic esterase to form DAF-2.
Intracellular DAF-2 is less membrane permeable due to its polarity, and is designed to be
trapped inside the cells. Because the fluorescence chemical transformation of DAF-2 by
NO is irreversible,57 the detected NO-sensitive fluorescence with DAF-2 represents a
cumulative production of NO. The slope of the FIDAF curve represents the NO production
rate and the plateau indicates the termination of NO production instead of the actual NO
145

concentration in the cells. To present the real-time course of NO production, df/dt, the NO
production rate, was calculated based on the differential conversion of that regression
equation (shown in Fig. 5a). Using this method, our study presented the basal NO
production rate and the changes in NO production after exposure to ATP in HUVECsdeveloped microvessels in the microfluidic device with temporal and spatial resolution for
the first time. The results are comparable to those derived from individually perfused intact
venules. These studies provide an in vivo validation of the functional aspect of engineered
microvessel network, which is instrumental for the utility of this device to the development
of biological applications.
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CONCLUSIONS
These results demonstrated in vitro formation of a microvessel network that
recapitulates key features of microvessels in vivo and validate its utility for biological
applications. The fabrication process of the microchannels was simple and straightforward
to lower the barrier for biologists. The cell seeding and culture with constant perfusion
method was user friendly to most researchers and easy to replicate. Cells in our model
keep their phenotype, viability, proliferation with proper barrier functions, and respond to
flow shear force and inflammatory stimuli. Comparing to other conventional in vitro models,
our model is more physiological realistic. In particular, HUVECs were successfully grown
to confluence throughout entire microchannels under well-controlled conditions. The model,
including in vitro growth endothelialized microchannels and the flow control, mimics
microscaled dimensions of in vivo microvessels and continuous flow patterns.
Immunofluorescent staining of VE-cadherin demonstrated the formation of vascular
endothelial junctions, an indication of well-maintained endothelial restrictive barrier
functions. HUVECs responded to different physiologically relevant flow shear stresses and
inflammatory stimuli. The endothelial [Ca2+]i, basal NO, and the changes in NO production
rate in response to ATP were real-time measured and quantified at individual cellular level
in Fluo 4 and DAF-2 loaded microvessels, respectively. The transient [Ca2+]i responses and
increased NO production in response to agonist application are similar to those observed
in individually perfused intact microvessels. The developed microvessel model has the
potential to bridge the gap between over-simplified in vitro tests and more expensive and
labour-intensive in vivo animal models for the microvascular signalling and functional
studies. It offers valuable quantitative insights into how biophysical and biochemical
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properties influence vascular biology and pathophysiology, serves as the complements for
in vivo animal studies. Because the cultured endothelial cells can be from human tissues,
a well characterized device will be suitable for studies of interactions between human blood
components with microvessels formed by human endothelial cells under physiological and
pathological conditions.
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FIGURES AND FIGURE LEGENDS

Figure. 1 The schematic fabrication procedures for the microfluidic microchannel
network. (a) A pre-cleaned silicon substrate; (b) SU-8 photoresist was spun-coated onto
the silicon wafer; (c) The photoresist was exposed to UV light through the photomask; (d)
The developed microchannel network pattern was used as the master mold; (e) The PDMS
mixing solution was cast onto the master mold and cured; (f) The inlet and the outlet were
punched and the microchannel device was bonded onto the substrate.
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Figure. 2 The representative confocal images show the HUVECs successfully
cultured throughout the inner surfaces of the entire microchannel network. (a) The
schematic image of the network with selected regions as shown in b-d; (b-d) HUVECs
were stained with F-actin and cell nuclei in each region, where b1, c1 and d1 show the
top surfaces of the channel, respectively. b2, c2 and d2 show the bottom surfaces of the
channel, respectively; (e) The cross-sectional images at each region. The locations of the
cross-sections were indicated as 1-1’, 2-2’, and 3-3’ in b1-d1, respectively. Scale bars:
100 µm.
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Figure. 3 The representative immunofluorescent confocal images demonstrated
the VE-Cadherin junctions formation throughout the entire network. (a) The
schematic image of the network with selected regions as shown in b-d; (b-c) VE-Cadherin
and cell nuclei staining were shown at the first and third branching regions; (d1-d2) VECadherin and cell nuclei staining were shown at the top and bottom surfaces of the
second branching regions, respectively; (e) Enlarged region indicated in (a). Scale bars:
100 µm
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Fig.4
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Figure. 4 HUVECs response to the different levels of shear stresses: The
morphology change was studied with F-actin staining. (a) The schematic image of
the network with the indicated selected region for shear stress test; (b) COMSOL
simulation shows the wall shear stress distribution in the selected region along the
network. (c-e) Confocal image showed the F-actin stress fibers under the LSC-LST, LSCHST, and HSC-HST respectively. (f) Aspect ratio comparing between the three testing
groups; (g) Comparing of the cell surface areas between the testing groups; All data are
reported as the means ± SE of independent experiment. Scale bars: 100 µm. *: P<0.05;
**: P<0.01; ***: P<0.001.
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Figure 5 ATP-induced endothelial cell [Ca2+]i increase in HUVECs cultured
microchannel network. (a) Time course of ATP-induced changes in endothelial [Ca2+]i
from a representative experiment; (b) Fluo-4 confocal images from one representative
experiment before and after the start of ATP perfusion at 60 and 160 seconds.
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Fig. 6
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Figure 6 ATP-induced NO production increases in HUVECs cultured microchannel
network. (a) Time dependent changes in FIDAF (left Y axis) from a representative
experiment before and after ATP (10 µM) stimulation with continuous perfusion of DAF-2
DA at 5 μM. The 1st differential conversion of cumulative FIDAF (df /dt, right Y axis)
represents the NO production rate (dash-dotted line); (b) Representative DAF-2
fluorescence images. ATP induced significant increases in nitric oxide (NO)-DAF-2
fluorescence intensity (FI) relative to control (left). FI was further increased with the
application of the NO donor sodium nitroprusside (SNP).
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CHAPTER 6
GENERAL DISCUSSION, CONCLUSION AND FUTURE STUDIES
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GENERAL DISCUSSION AND CONCLUSION
Unchecked increase in microvessel permeability can lead to a variety of cardiovascular
diseases. A deep and integrative understanding of the mechanisms of NO and shear stress
participating in the regulation of microvascular permeability could provide new perspective
into those diseases, which may eventually contribute to inventing potential therapeutic
strategies.
The role of NO in regulating microvessel permeability has been debated for more than
a decade. The study in Chapter 2 demonstrated for the first time that exogenously applied
AP-CAV, a specific eNOS inhibitor, has been shown to not only inhibit inflammatory
stimulus-induced increases in NO production and microvessel permeability,1-3 but also
reduce basal NO production in endothelial cells lining microvessel walls. Furthermore, the
study suggested that reducing basal NO by AP-CAV did not directly change basal
microvessel permeability, but it increased the adhesive capacity of endothelial cells and
promotes leukocyte adhesion via Src-mediated phosphorylation of ICAM-1. Meanwhile, a
NO donor, SNP, abolished the effect of AP-CAV on increased ICAM-1 binding to a blocking
antibody and leukocyte adhesion, and further supported that the anti-adhesive property of
basal NO in maintaining the homeostasis of vascular walls.
In addition to the mechanism of CAV-induced leukocyte adhesion, we found that CAVinduced leukocytes adhesion does not increase microvessel permeability, which was
further approved by the observation of the intact and continuous VE-cadherin on
endothelial junction. Previously, our study showed that TNF-α-induced leukocyte adhesion
and migration are not sufficient to cause increases in microvessel permeability.4 Although
the interaction of leukocytes with endothelial cells has been considered as the critical event
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leading to permeability increase, there are also increasing evidences demonstrating the
dissociation between leukocyte adhesion and changes in permeability.5, 6 Studies in rat
tracheal mucosa found that 94% of the gap junctions were distinct from sites of leukocyte
adhesion or migration in the leaky venules.

7, 8

Valeski et al demonstrated that blocking

histamine-associated adherent leukocytes had no significant effect on leakage formation.9
Furthermore, previous studies from our lab and others suggested that it is the additional
stimuli that induced leukocyte oxidative burst which, in turn, are responsible for the
increased microvessel permeability.

4, 10-13

Our previous study demonstrated that fMLP-

induced ROS production in adhered leukocytes to vascular wall was one of the
mechanisms responsible for the increased permeability in TNF-α primed rat mesenteric
venules.10 In further support of this hypothesis, in the current study, we observed a transient
increase in microvessel permeability only upon fMLP (10 μM) perfusion in the presence of
AP-CAV-induced adherent leukocytes. Our finding that AP-CAV-induced leukocytes
adhesion does not increase permeability consolidates the theory that adhesive interactions
between leucocytes and endothelial cells is independent from the potential endothelial
damage caused by leukocyte ROS release and therefore is dissociated from increases in
microvessel permeability.
Other than chemical stimulation, mechanical force stimulation also has been suggested
play an important role in the regulation of microvessel permeability. Wall SS is the
tangential force exerted per unit area of the blood-endothelium surface. Post-capillary
venules are the main sites where the permeability increase and recruitment of leukocytes
occur during inflammation. Only a few in vivo studies investigating whether the shear stress
(by either increase perfusion pressure or shear rate) affect microvessel Lp in frog or rat
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mesentery venules.14-16 Unfortunately, these studies provide contradicting results. In those
studies, none of them involving blood cell components, which are always present in the
blood stream. Our results in Chapter 3 indicated that in intact venules ATP released from
RBCs in response to a sudden change of SS is responsible for the increases in EC [Ca2+]i
and vascular permeability, whereas SS-induced EC NO production can be independent of
increased EC [Ca2+]i. It may provide the basic mechanisms that help to explain and predict
the roles of acute changes in SS in different vasculature under both physiological and
pathological conditions. Under physiological condition, variations in vascular geometry
could cause the RBCs experienced high SS at small vessel region, which may release
increased amount of ATP and cause increases in EC [Ca2+]i and gap formation at
downstream vessels. Under pathological conditions, such as vascular lumen narrowing due
to the atherosclerotic plaque formation, or injury-induced local cell proliferation, sudden
increases in SS and increased ATP release may dramatically affect the downstream vessel
segment permeability and exaggerate the local inflammation.
Other than the question we discussed in Chapter 3: ‘How blood flow-generated shear
stress regulates microvessel permeability?’, another mystery waiting for resolving is ‘how
endothelial cells sense the shear stress?’. Up to now, there are several mechanosensor
candidates have been proposed, such as ion channels,17 G-protein-coupled receptors
(GPCRs),

18

caveolae,

19

adhesion proteins,20 and the glycocalyx.21 The glycocalyx is a

layer of proteoglycans covering the endothelium. It has been indicated to be a
mechanotransduction sensor for changes of shear stress.22 An impaired glycocalyx has
been suggested to contribute to the increased leukocyte adhesion, hyperpermeability, and
other microvascular dysfunctions associated with diabetes and other cardiovascular
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diseases. In Chapter 4, we found the impaired glycocalyx increases the endothelial
susceptibility to shear stress, which augmented NO production in microvessels of diabetic
rats. Similar enhanced NO production has also been found in pronase treated normal
vessel. The results implicates that glycocalyx may serves to reduce the fluid shear stress
at the surface of the membrane where most receptors are located that could serve as
mechanosensor.
Besides in vivo study of microvessel, in Chapter 5, we demonstrated in vitro formation
of a microvessel network that recapitulates key features of microvessels in vivo and validate
its utility for biological applications. Microfluidic model has been indicated could have a
great potential for biological applications and bridging the gaps between in vitro and in vivo
microvascular research. Comparing to other conventional in vitro models, our model is
more physiological relevant. Firstly, endothelialized microchannels are under flow control,
which mimics microscaled dimensions of in vivo microvessels with continuous flow.
Secondly, immunofluorescence staining of VE-cadherin and F-actin demonstrated the
formation of vascular endothelial junctions and well developed cytoskeleton, two important
characters indicating well-maintained endothelial barrier functions. Thirdly, engineered
microvessels EC transient [Ca2+]i responses and increased NO production in response to
agonist application are similar to those observed in individually perfused intact
microvessels. Overall, it suggested that the developed microvessel model has the potential
to bridge the gap between over-simplified in vitro tests and more expensive and laborintensive in vivo animal models for the microvascular signaling and functional studies. Also,
by culturing an individual human subject’s cells or perfusing human subject’s blood or fluid,
it offers valuable clinical significance under both physiological and pathological conditions.
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Overall, this dissertation demonstrated the important role of basal NO in the regulation
of microvessel permeability and leukocyte adhesion, the critical role of blood flow generated
shear stress in endothelial cell signaling and microvessel permeability in vivo, the effect of
impaired glycocalyx in diabetic rat venules in its response to shear stress, and also the
potential usage of microfluidic devices in microvascular research.

166

SIGNIFICANCE OF THE STUDY
Despite years of studies, the exact roles of NO in the regulation of microvessel
permeability remain controversial. The study in Chapter 2 was conducted in intact
microvessels under basal conditions. Combined with our previous findings on inflammatory
stimuli-induced NO and microvessel permeability, 1-3, 23 we revealed dual actions of NO on
endothelial functions using the same experimental preparation, but under different
conditions, which provides a unified perspective of the roles of NO in the regulation of
endothelial function and microvessel permeability.
Previous studies of the effects of SS on vascular endothelium were mainly conducted
in the absence of blood cell components either in cultured endothelial monolayers 24, 25 or
in individually perfused microvessels.14-16 Whereas the studies of the effects of shear on
blood cells, such as RBCs, usually do not involve vascular endothelium.26-28 Our studies by
direct comparisons of intact microvascular responses to SS generated by uniform fluids,
such as plasma or solutions containing Dextran 70, with SS generated by blood flow
demonstrated that under physiological conditions, i.e. in blood perfused microvessels, the
changes of blood flow affect endothelium not only by fluid-generated wall SS, but also by
shear-induced ATP release from RBCs. Our results in Chapter 3 indicated that an increase
of fluid-generated wall SS induces increased endothelial cell NO production, which does
not involve an increase in endothelial [Ca2+]i. However, under in vivo conditions, i.e. in blood
perfused vessels, the increased shear exerted on RBCs induces shear-magnitude
dependent ATP release. This SS-dependent ATP release from RBCs causes increases in
endothelial [Ca2+]i and endothelial gap formation, an indication of increases in microvessel
permeability. By linking the effects of wall SS on endothelium with the effects of shear
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induced ATP release from RBCs on endothelium, our study provided new insight about
how changes of blood flow affect vascular functions in vivo.
Most of the experiments in our study have been conducted in individually perfused
microvessels with undisturbed surrounding circulation, which we consider extremely
important. In order to translate the remarkable knowledge gained from in vitro studies into
clinical therapeutic applications, it is essential to evaluate cellular and molecular
mechanisms in their native state. Multidimensional protein identification revealed that 41%
of proteins expressed in vivo are not detected in vitro, indicating that distinct in vivo protein
expression is apparently regulated by the tissue microenvironment and cannot yet be
duplicated in standard cell culture.29 This is specifically important for glycocalyx studies,
because the glycocalyx under static cultured cell growth is not as well developed as that
under physiological conditions. 30
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FUTURE STUDIES
The dissertation has demonstrated that NO and SS play important roles in the regulation
of microvessel permeability. There are still many questions worth further exploration.
In Chapter 2, the timing of rapid increased ICAM-1 staining induced by AP-CAV
perfusion ruled out the possibility of new ICAM-1 protein synthesis. However, our results
could not enable us to rule out the possibility of membrane translocation of ICAM-1 in
response to AP-CAV-induced NO reduction. TNF-α-induced early phase leukocyte
adhesion involves the activation of constitutive ICAM-1 on cell surface, which is
demonstrated by protein analysis from cytoplasmic and membrane fractions in cultured
cells.

31

In order to pursue the detailed molecular mechanism of AP-CAV induced rapid

increase of EC ICAM-1 affinity to leukocyte, with collaboration with an in vitro research
group, we are going to first verify our finding on cultured cells and then using western
blotting, Real time PCR and other molecular techniques to study the change of EC ICAM1 from both cytosol and cell membrane upon the stimulation of AP-CAV.
In Chapter 3, we found both plasma and blood-generated shear stress induced shearmagnitude dependent EC NO production increase. Interestingly, plasma perfusion
generated change of shear stress caused more EC production than that of blood perfusion.
However, eNOS ser1177 and Thr495 immunofluorescence staining revealed that blood
perfusion resulted in same extent of eNOS activation as plasma did. We hypothesized that
it may due to hemoglobin in the RBCs scavenge the EC NO induced by the blood perfusion.
To test this hypothesis, we could use CO to uncover role of NO binding to hemoglobin. We
could perfuse carbon monoxide blood into our microvessel to see whether it generated
more EC NO production than that of blood perfusion.
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Also, in Chapter 3, we used carbenoxolone to test our hypothesis that Pannexin 1
channel is the one responsible for the ATP releasing from RBCs triggered by shear stress.
Carbenoxolone is an unspecific gap junction blocker, and has been demonstrated strongly
inhibited Pannexin 1 ((IC50 = 5 μm).32 Other than ubiquitously expressed Pannexin 1
channel, Pannexin family also has Pannexin 2, and Pannexin 3 channel as its family
members. Pannexin 1 was first demonstrated to act as an ATP-permeant channel on RBCs
in 2006.

33

In order to rule out the Pannexin 2 and Pannexin 3’s possibilities involving in

shear stress induced ATP releasing from RBCs, we would further investigate the role of
Pannexin 1 channel using Pannexin 1 channel genetic knockout mice.
The glycocalyx has been indicated as a mechanotransduction sensor to the fluid shear
stress in many in vitro studies.22, 34-36 Using enzyme degradation of its specific components
impaired the shear stress induced NO production and increased permeability in vitro.37 In
Chapter 4, our results suggested that loss or impaired EC glycocalyx enhanced EC NO
production to shear stress. Based on the cell culture studies, removing hyaluronic acid
(HA), sialic acids (SA), heparin sulfate (HS) but not chondroitin sulfate (CS) abolished NO
production.38 Some studies reported that removing HA, HS, CS blocked shear-induced
increases in Lp. Our future study will use glycocalyx component-specific enzymes
individually or in combination to degrade the glycocalyx, which enable us to differentiate
the roles of different glycocalyx components in shear stress-induced NO production in intact
microvessels. Meanwhile, since NO is an important regulator in microvessel permeability
and leukocyte adhesion. It is also interesting to investigate the role of glycocalyx in
microvessel permeability and leukocyte adhesion.
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